{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:47:27Z","timestamp":1787024847628,"version":"build-2736575974"},"reference-count":393,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>There are different modalities of intercellular communication governed by cellular homeostasis.\nIn this review, we will explore one of these forms of communication called extracellular\nvesicles (EVs). These vesicles are released by all cells in the body and are heterogeneous in nature.\nThe primary function of EVs is to share information through their cargo consisting of proteins, lipids\nand nucleic acids (mRNA, miRNA, dsDNA etc.) with other cells, which have a direct consequence\non their microenvironment. We will focus on the role of EVs of mesenchymal stem cells\n(MSCs) in the nervous system and how these participate in intercellular communication to maintain\nphysiological function and provide neuroprotection. However, deregulation of this same communication\nsystem could play a role in several neurodegenerative diseases, such as Alzheimer\u2019s disease,\nParkinson\u2019s disease, Amyotrophic lateral sclerosis, multiple sclerosis, prion disease and Huntington\u2019s\ndisease. The release of EVs from a cell provides crucial information to what is happening inside\nthe cell and thus could be used in diagnostics and therapy. We will discuss and explore new avenues\nfor the clinical applications of using engineered MSC-EVs and their potential therapeutic\nbenefit in treating neurodegenerative diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570159x19666210817150141","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T07:44:53Z","timestamp":1629445493000},"page":"1450-1478","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration"],"prefix":"10.2174","volume":"20","author":[{"given":"Ayaz M.","family":"Belkozhayev","sequence":"first","affiliation":[{"name":"Al-Farabi Kazakh National University, Faculty of Biology and Biotechnology, Almaty, Republic of Kazakhstan"},{"name":"Structural and Functional Genomics Laboratory of M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry,\nAlmaty, Republic of Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnatallah","family":"Al-Yozbaki","sequence":"additional","affiliation":[{"name":"Canterbury Christ Church University, School of Human and Life Sciences, Life Sciences\nIndustry Liaison Lab, Sandwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"George","sequence":"additional","affiliation":[{"name":"Canterbury Christ Church University, School of Human and Life Sciences, Life Sciences\nIndustry Liaison Lab, Sandwich, UK"},{"name":"Jubilee Centre for Medical Research, Jubilee Mission Medical College &amp; Research Institute, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raigul","family":"Ye Niyazova","sequence":"additional","affiliation":[{"name":"Al-Farabi Kazakh National University, Faculty of Biology and Biotechnology, Almaty, Republic of Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalidin O.","family":"Sharipov","sequence":"additional","affiliation":[{"name":"Structural and Functional Genomics Laboratory of M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry,\nAlmaty, Republic of Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee J.","family":"Byrne","sequence":"additional","affiliation":[{"name":"Canterbury Christ Church University, School of Human and Life Sciences, Life Sciences\nIndustry Liaison Lab, Sandwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Canterbury Christ Church University, School of Human and Life Sciences, Life Sciences\nIndustry Liaison Lab, Sandwich, UK"},{"name":"University of Liverpool, Institute of Translation Medicine, Dept of Molecular\n&amp; Clinical, Cancer Medicine, UK"},{"name":"Novel Global Community Educational Foundation, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arr.2016.11.002","volume":"34","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Ji X.; Leak R.K.; Chen F.; Cao G.; Stem cell therapies in age-related neurodegenerative diseases and stroke. Ageing Res Rev 2017,34,39-50","journal-title":"Ageing Res Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"Lee R.H.","year":"2009","unstructured":"Lee R.H.; Pulin A.A.; Seo M.J.; Kota D.J.; Ylostalo J.; Larson B.L.; Semprun-Prieto L.; Delafontaine P.; Prockop D.J.; Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009,5(1),54-63","journal-title":"Cell Stem Cell"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2007.01.045","volume":"354","author":"Iso Y.","year":"2007","unstructured":"Iso Y.; Spees J.L.; Serrano C.; Bakondi B.; Pochampally R.; Song Y.H.; Sobel B.E.; Delafontaine P.; Prockop D.J.; Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 2007,354(3),700-706","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000047856","volume":"169","author":"Gao J.","year":"2001","unstructured":"Gao J.; Dennis J.E.; Muzic R.F.; Lundberg M.; Caplan A.I.; The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001,169(1),12-20","journal-title":"Cells Tissues Organs"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"C303","DOI":"10.1152\/ajpcell.00129.2019","volume":"317","author":"Bruno S.","year":"2019","unstructured":"Bruno S.; Chiabotto G.; Favaro E.; Deregibus M.C.; Camussi G.; Role of extracellular vesicles in stem cell biology. Am J Physiol Cell Physiol 2019,317(2),C303-C313","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"Lai R.C.","year":"2010","unstructured":"Lai R.C.; Arslan F.; Lee M.M.; Sze N.S.; Choo A.; Chen T.S.; Salto-Tellez M.; Timmers L.; Lee C.N.; El Oakley R.M.; Pasterkamp G.; de Kleijn D.P.; Lim S.K.; Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res (Amst) 2010,4(3),214-222","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2008070798","volume":"20","author":"Bruno S.","year":"2009","unstructured":"Bruno S.; Grange C.; Deregibus M.C.; Calogero R.A.; Saviozzi S.; Collino F.; Morando L.; Busca A.; Falda M.; Bussolati B.; Tetta C.; Camussi G.; Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009,20(5),1053-1067","journal-title":"J Am Soc Nephrol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"van Niel G.","year":"2018","unstructured":"van Niel G.; D\u2019Angelo G.; Raposo G.; Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 2018,19(4),213-228","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"Skog J.","year":"2008","unstructured":"Skog J.; W&#xFC;rdinger T.; van Rijn S.; Meijer D.H.; Gainche L.; Sena-Esteves M.; Curry W.T.; Carter B.S.; Krichevsky A.M.; Breake-field X.O.; Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008,10(12),1470-1476","journal-title":"Nat Cell Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1038\/ncomms8029","volume":"6","author":"Lai C.P.","year":"2015","unstructured":"Lai C.P.; Kim E.Y.; Badr C.E.; Weissleder R.; Mempel T.R.; Tannous B.A.; Breakefield X.O.; Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat Commun 2015,6,7029","journal-title":"Nat Commun"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.leu.2404132","volume":"20","author":"Ratajczak J.","year":"2006","unstructured":"Ratajczak J.; Miekus K.; Kucia M.; Zhang J.; Reca R.; Dvorak P.; Ratajczak M.Z.; Embryonic stem cell-derived microvesicles repro-gram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006,20(5),847-856","journal-title":"Leukemia"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"Valadi H.","year":"2007","unstructured":"Valadi H.; Ekstr&#xF6;m K.; Bossios A.; Sj&#xF6;strand M.; Lee J.J.; L&#xF6;tvall J.O.; Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007,9(6),654-659","journal-title":"Nat Cell Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"Zhuang X.","year":"2011","unstructured":"Zhuang X.; Xiang X.; Grizzle W.; Sun D.; Zhang S.; Axtell R.C.; Ju S.; Mu J.; Zhang L.; Steinman L.; Miller D.; Zhang H.G.; Treat-ment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 2011,19(10),1769-1779","journal-title":"Mol Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"Uccelli A.","year":"2008","unstructured":"Uccelli A.; Moretta L.; Pistoia V.; Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008,8(9),726-736","journal-title":"Nat Rev Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1634\/stemcells.21-1-105","volume":"21","author":"Romanov Y.A.","year":"2003","unstructured":"Romanov Y.A.; Svintsitskaya V.A.; Smirnov V.N.; Searching for alternative sources of postnatal human mesenchymal stem cells: candi-date MSC-like cells from umbilical cord. Stem Cells 2003,21(1),105-110","journal-title":"Stem Cells"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","volume":"13","author":"Zuk P.A.","year":"2002","unstructured":"Zuk P.A.; Zhu M.; Ashjian P.; De Ugarte D.A.; Huang J.I.; Mizuno H.; Alfonso Z.C.; Fraser J.K.; Benhaim P.; Hedrick M.H.; Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002,13(12),4279-4295","journal-title":"Mol Biol Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2003-04-1291","volume":"102","author":"In \u2019t Anker P.S.","year":"2003","unstructured":"In \u2019t Anker P.S.; Scherjon S.A.; Kleijburg-van der Keur C.; Noort W.A.; Claas F.H.; Willemze R.; Fibbe W.E.; Kanhai H.H.; Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003,102(4),1548-1549","journal-title":"Blood"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1634\/stemcells.22-5-649","volume":"22","author":"Fukuchi Y.","year":"2004","unstructured":"Fukuchi Y.; Nakajima H.; Sugiyama D.; Hirose I.; Kitamura T.; Tsuji K.; Human placenta-derived cells have mesenchymal stem\/progenitor cell potential. Stem Cells 2004,22(5),649-658","journal-title":"Stem Cells"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-60761-705-1_5","volume":"660","author":"Boyle A.J.","year":"2010","unstructured":"Boyle A.J.; McNiece I.K.; Hare J.M.; Mesenchymal stem cell therapy for cardiac repair. Methods Mol Biol 2010,660,65-84","journal-title":"Methods Mol Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.diff.2011.06.003","volume":"82","author":"Bhandari D.R.","year":"2011","unstructured":"Bhandari D.R.; Seo K.W.; Sun B.; Seo M.S.; Kim H.S.; Seo Y.J.; Marcin J.; Forraz N.; Roy H.L.; Larry D.; Colin M.; Kang K.S.; The simplest method for in vitro &#x3B2;-cell production from human adult stem cells. Differentiation 2011,82(3),144-152","journal-title":"Differentiation"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.21704","volume":"46","author":"Banas A.","year":"2007","unstructured":"Banas A.; Teratani T.; Yamamoto Y.; Tokuhara M.; Takeshita F.; Quinn G.; Okochi H.; Ochiya T.; Adipose tissue-derived mesen-chymal stem cells as a source of human hepatocytes. Hepatology 2007,46(1),219-228","journal-title":"Hepatology"},{"key":"ref=22","first-page":"244","volume":"14","author":"Pournasr B.","year":"2011","unstructured":"Pournasr B.; Mohamadnejad M.; Bagheri M.; Aghdami N.; Shahsavani M.; Malekzadeh R.; Baharvand H.; In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arch Iran Med 2011,14(4),244-249","journal-title":"Arch Iran Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3892\/mmr.2014.2935","volume":"11","author":"Yin L.","year":"2015","unstructured":"Yin L.; Zhu Y.; Yang J.; Ni Y.; Zhou Z.; Chen Y.; Wen L.; Adipose tissue-derived mesenchymal stem cells differentiated into hepato-cyte-like cells in vivo and in vitro. Mol Med Rep 2015,11(3),1722-1732","journal-title":"Mol Med Rep"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1126\/science.279.5356.1528","volume":"279","author":"Ferrari G.","year":"1998","unstructured":"Ferrari G.; Cusella-De Angelis G.; Coletta M.; Paolucci E.; Stornaiuolo A.; Cossu G.; Mavilio F.; Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998,279(5356),1528-1530","journal-title":"Science"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.RES.0000109792.43271.47","volume":"94","author":"Planat-B&#xE9;nard V.","year":"2004","unstructured":"Planat-B&#xE9;nard V.; Menard C.; Andr&#xE9; M.; Puceat M.; Perez A.; Garcia-Verdugo J.M.; P&#xE9;nicaud L.; Casteilla L.; Spontaneous cardiomy-ocyte differentiation from adipose tissue stroma cells. Circ Res 2004,94(2),223-229","journal-title":"Circ Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"12167","DOI":"10.1073\/pnas.0604850103","volume":"103","author":"Rodr&#xED;guez L.V.","year":"2006","unstructured":"Rodr&#xED;guez L.V.; Alfonso Z.; Zhang R.; Leung J.; Wu B.; Ignarro L.J.; Clonogenic multipotent stem cells in human adipose tissue differ-entiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006,103(32),12167-12172","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/exnr.2000.7389","volume":"164","author":"Sanchez-Ramos J.","year":"2000","unstructured":"Sanchez-Ramos J.; Song S.; Cardozo-Pelaez F.; Hazzi C.; Stedeford T.; Willing A.; Freeman T.B.; Saporta S.; Janssen W.; Patel N.; Cooper D.R.; Sanberg P.R.; Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000,164(2),247-256","journal-title":"Exp Neurol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1432-0436.2006.00110.x","volume":"75","author":"Wosnitza M.","year":"2007","unstructured":"Wosnitza M.; Hemmrich K.; Groger A.; Gr&#xE4;ber S.; Pallua N.; Plasticity of human adipose stem cells to perform adipogenic and endothe-lial differentiation. Differentiation 2007,75(1),12-23","journal-title":"Differentiation"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/152581600750062264","volume":"9","author":"Majumdar M.K.","year":"2000","unstructured":"Majumdar M.K.; Thiede M.A.; Haynesworth S.E.; Bruder S.P.; Gerson S.L.; Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000,9(6),841-848","journal-title":"J Hematother Stem Cell Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000128968","volume":"35","author":"Bifari F.","year":"2008","unstructured":"Bifari F.; Lisi V.; Mimiola E.; Pasini A.; Krampera M.; Immune modulation by mesenchymal stem cells. Transfus Med Hemother 2008,35(3),194-204","journal-title":"Transfus Med Hemother"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"Forbes G.M.","year":"2014","unstructured":"Forbes G.M.; Sturm M.J.; Leong R.W.; Sparrow M.P.; Segarajasingam D.; Cummins A.G.; Phillips M.; Herrmann R.P.; A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn\u2019s disease refractory to biologic therapy. Clin Gastroenterol Hepatol 2014,12(1),64-71","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"Gonz&#xE1;lez M.A.","year":"2009","unstructured":"Gonz&#xE1;lez M.A.; Gonzalez-Rey E.; Rico L.; B&#xFC;scher D.; Delgado M.; Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009,136(3),978-989","journal-title":"Gastroenterology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"Le Blanc K.","year":"2003","unstructured":"Le Blanc K.; Tammik C.; Rosendahl K.; Zetterberg E.; Ringd&#xE9;n O.; HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003,31(10),890-896","journal-title":"Exp Hematol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"Aggarwal S.","year":"2005","unstructured":"Aggarwal S.; Pittenger M.F.; Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005,105(4),1815-1822","journal-title":"Blood"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"Corcione A.","year":"2006","unstructured":"Corcione A.; Benvenuto F.; Ferretti E.; Giunti D.; Cappiello V.; Cazzanti F.; Risso M.; Gualandi F.; Mancardi G.L.; Pistoia V.; Uccel-li A.; Human mesenchymal stem cells modulate B-cell functions. Blood 2006,107(1),367-372","journal-title":"Blood"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"Jiang X.X.","year":"2005","unstructured":"Jiang X.X.; Zhang Y.; Liu B.; Zhang S.X.; Wu Y.; Yu X.D.; Mao N.; Human mesenchymal stem cells inhibit differentiation and func-tion of monocyte-derived dendritic cells. Blood 2005,105(10),4120-4126","journal-title":"Blood"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"Nauta A.J.","year":"2007","unstructured":"Nauta A.J.; Fibbe W.E.; Immunomodulatory properties of mesenchymal stromal cells. Blood 2007,110(10),3499-3506","journal-title":"Blood"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","volume":"164","author":"Shi M.","year":"2011","unstructured":"Shi M.; Liu Z.W.; Wang F.S.; Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011,164(1),1-8","journal-title":"Clin Exp Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/jgm.452","volume":"5","author":"Chapel A.","year":"2003","unstructured":"Chapel A.; Bertho J.M.; Bensidhoum M.; Fouillard L.; Young R.G.; Frick J.; Demarquay C.; Cuvelier F.; Mathieu E.; Trompier F.; Dudoignon N.; Germain C.; Mazurier C.; Aigueperse J.; Borneman J.; Gorin N.C.; Gourmelon P.; Thierry D.; Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003,5(12),1028-1038","journal-title":"J Gene Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.biomaterials.2010.08.101","volume":"32","author":"Fong E.L.","year":"2011","unstructured":"Fong E.L.; Chan C.K.; Goodman S.B.; Stem cell homing in musculoskeletal injury. Biomaterials 2011,32(2),395-409","journal-title":"Biomaterials"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1259\/bjr\/25927054","volume":"80","author":"Mouiseddine M.","year":"2007","unstructured":"Mouiseddine M.; Fran&#xE7;ois S.; Semont A.; Sache A.; Allenet B.; Mathieu N.; Frick J.; Thierry D.; Chapel A.; Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes\/severe combined immunodeficiency mouse model. Br J Radiol 2007,80(Spec No 1),S49-S55","journal-title":"Br J Radiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"Kidd S.","year":"2009","unstructured":"Kidd S.; Spaeth E.; Dembinski J.L.; Dietrich M.; Watson K.; Klopp A.; Battula V.L.; Weil M.; Andreeff M.; Marini F.C.; Direct evi-dence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009,27(10),2614-2623","journal-title":"Stem Cells"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/path.5357","volume":"250","author":"Galland S.","year":"2020","unstructured":"Galland S.; Stamenkovic I.; Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression. J Pathol 2020,250(5),555-572","journal-title":"J Pathol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e0229606","DOI":"10.1371\/journal.pone.0229606","volume":"15","author":"Kirchner B.","year":"2020","unstructured":"Kirchner B.; Buschmann D.; Paul V.; Pfaffl M.W.; Postprandial transfer of colostral extracellular vesicles and their protein and miRNA cargo in neonatal calves. PLoS One 2020,15(2),e0229606","journal-title":"PLoS One"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1639854","DOI":"10.1155\/2019\/1639854","volume":"2019","author":"Cufaro M.C.","year":"2019","unstructured":"Cufaro M.C.; Pieragostino D.; Lanuti P.; Rossi C.; Cicalini I.; Federici L.; De Laurenzi V.; Del Boccio P.; Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics. J Oncol 2019,2019,1639854","journal-title":"J Oncol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"Th&#xE9;ry C.","year":"2018","unstructured":"Th&#xE9;ry C.; Witwer K.W.; Aikawa E.; Alcaraz M.J.; Anderson J.D.; Andriantsitohaina R.; Antoniou A.; Arab T.; Archer F.; Atkin-Smith G.K.; Ayre D.C.; Bach J.M.; Bachurski D.; Baharvand H.; Balaj L.; Baldacchino S.; Bauer N.N.; Baxter A.A.; Bebawy M.; Beckham C.; Bedina Zavec A.; Benmoussa A.; Berardi A.C.; Bergese P.; Bielska E.; Blenkiron C.; Bobis-Wozowicz S.; Boilard E.; Boireau W.; Bongiovanni A.; Borr&#xE0;s F.E.; Bosch S.; Boulanger C.M.; Breakefield X.; Breglio A.M.; Brennan M.A.; Brigstock D.R.; Brisson A.; Broekman M.L.; Bromberg J.F.; Bryl-G&#xF3;recka P.; Buch S.; Buck A.H.; Burger D.; Busatto S.; Buschmann D.; Bussolati B.; Buz&#xE1;s E.I.; Byrd J.B.; Camussi G.; Carter D.R.; Caruso S.; Chamley L.W.; Chang Y.T.; Chen C.; Chen S.; Cheng L.; Chin A.R.; Clayton A.; Clerici S.P.; Cocks A.; Cocucci E.; Coffey R.J.; Cordeiro-da-Silva A.; Couch Y.; Coumans F.A.; Coyle B.; Crescitelli R.; Criado M.F.; D\u2019Souza-Schorey C.; Das S.; Datta Chaudhuri A.; de Candia P.; De Santana E.F.; De Wever O.; Del Portillo H.A.; De-maret T.; Deville S.; Devitt A.; Dhondt B.; Di Vizio D.; Dieterich L.C.; Dolo V.; Dominguez Rubio A.P.; Dominici M.; Dourado M.R.; Driedonks T.A.; Duarte F.V.; Duncan H.M.; Eichenberger R.M.; Ekstr&#xF6;m K.; El Andaloussi S.; Elie-Caille C.; Erdbr&#xFC;gger U.; Falc&#xF3;n-P&#xE9;rez J.M.; Fatima F.; Fish J.E.; Flores-Bellver M.; F&#xF6;rs&#xF6;nits A.; Frelet-Barrand A.; Fricke F.; Fuhrmann G.; Gabrielsson S.; G&#xE1;mez-Valero A.; Gardiner C.; G&#xE4;rtner K.; Gaudin R.; Gho Y.S.; Giebel B.; Gilbert C.; Gimona M.; Giusti I.; Goberdhan D.C.; G&#xF6;rgens A.; Gorski S.M.; Greening D.W.; Gross J.C.; Gualerzi A.; Gupta G.N.; Gustafson D.; Handberg A.; Haraszti R.A.; Harrison P.; Hegyesi H.; Hendrix A.; Hill A.F.; Hochberg F.H.; Hoffmann K.F.; Holder B.; Holthofer H.; Hosseinkhani B.; Hu G.; Huang Y.; Huber V.; Hunt S.; Ibrahim A.G.; Ikezu T.; Inal J.M.; Isin M.; Ivanova A.; Jackson H.K.; Jacobsen S.; Jay S.M.; Jayachandran M.; Jenster G.; Jiang L.; Johnson S.M.; Jones J.C.; Jong A.; Jovanovic-Talisman T.; Jung S.; Kalluri R.; Kano S.I.; Kaur S.; Kawamura Y.; Keller E.T.; Khamari D.; Khomyakova E.; Khvorova A.; Kierulf P.; Kim K.P.; Kislinger T.; Klingeborn M.; Klinke D.J.; Kornek M.; Kosanovi\u0107 M.M.; Kov&#xE1;cs, A.F.; Kr&#xE4;mer-Albers, E.M.; Krasemann, S.; Krause, M.; Kurochkin, I.V.; Kusuma, G.D.; Kuypers, S.; Laitinen, S.; Langevin, S.M.; Languino, L.R.; Lannigan, J.; L&#xE4;sser, C.; Laurent, L.C.; Lavieu, G.; L&#xE1;zaro-Ib&#xE1;&#xF1;ez, E.; Le Lay, S.; Lee, M.S.; Lee, Y.X.F.; Lemos, D.S.; Lenassi, M.; Leszczynska, A.; Li, I.T.; Liao, K.; Libregts, S.F.; Ligeti, E.; Lim, R.; Lim, S.K.; Lin\u0113 A.; Linnemannst&#xF6;ns, K.; Llorente, A.; Lombard, C.A.; Lorenowicz, M.J.; L&#xF6;rincz, A.M.; L&#xF6;tvall, J.; Lovett, J.; Lowry, M.C.; Loyer, X.; Lu, Q.; Lukomska, B.; Lunavat, T.R.; Maas, S.L.; Malhi, H.; Marcilla, A.; Mariani, J.; Mariscal, J.; Martens-Uzunova, E.S.; Martin-Jaular, L.; Martinez, M.C.; Martins, V.R.; Mathieu, M.; Mathivanan, S.; Maugeri, M.; McGinnis, L.K.; McVey, M.J.; Meckes, D.G., Jr; Meehan, K.L.; Mertens, I.; Minciacchi, V.R.; M&#xF6;ller, A.; M&#xF8;ller J&#xF8;rgensen, M.; Morales-Kastresana, A.; Morhayim, J.; Mullier, F.; Mura-ca, M.; Musante, L.; Mussack, V.; Muth, D.C.; Myburgh, K.H.; Najrana, T.; Nawaz, M.; Nazarenko, I.; Nejsum, P.; Neri, C.; Neri, T.; Nieuwland, R.; Nimrichter, L.; Nolan, J.P.; Nolte-\u2019t Hoen, E.N.; Noren Hooten, N.; O\u2019Driscoll, L.; O\u2019Grady, T.; O\u2019Loghlen, A.; Ochiya, T.; Olivier, M.; Ortiz, A.; Ortiz, L.A.; Osteikoetxea, X.; &#xD8;stergaard, O.; Ostrowski, M.; Park, J.; Pegtel, D.M.; Peinado, H.; Perut, F.; Pfaffl, M.W.; Phinney, D.G.; Pieters, B.C.; Pink, R.C.; Pisetsky, D.S.; Pogge von Strandmann, E.; Polakovicova, I.; Poon, I.K.; Powell, B.H.; Pra-da, I.; Pulliam, L.; Quesenberry, P.; Radeghieri, A.; Raffai, R.L.; Raimondo, S.; Rak, J.; Ramirez, M.I.; Raposo, G.; Rayyan, M.S.; Regev-Rudzki, N.; Ricklefs, F.L.; Robbins, P.D.; Roberts, D.D.; Rodrigues, S.C.; Rohde, E.; Rome, S.; Rouschop, K.M.; Rughetti, A.; Russell, A.E.; Sa&#xE1;, P.; Sahoo, S.; Salas-Huenuleo, E.; S&#xE1;nchez, C.; Saugstad, J.A.; Saul, M.J.; Schiffelers, R.M.; Schneider, R.; Sch&#xF8;yen, T.H.; Scott, A.; Shahaj, E.; Sharma, S.; Shatnyeva, O.; Shekari, F.; Shelke, G.V.; Shetty, A.K.; Shiba, K.; Siljander, P.R.; Silva, A.M.; Skowronek, A.; Snyder, O.L., II; Soares, R.P.; S&#xF3;dar, B.W.; Soekmadji, C.; Sotillo, J.; Stahl, P.D.; Stoorvogel, W.; Stott, S.L.; Strasser, E.F.; Swift, S.; Taha-ra, H.; Tewari, M.; Timms, K.; Tiwari, S.; Tixeira, R.; Tkach, M.; Toh, W.S.; Tomasini, R.; Torrecilhas, A.C.; Tosar, J.P.; Toxavidis, V.; Urbanelli, L.; Vader, P.; van Balkom, B.W.; van der Grein, S.G.; Van Deun, J.; van Herwijnen, M.J.; Van Keuren-Jensen, K.; van Niel, G.; van Royen, M.E.; van Wijnen, A.J.; Vasconcelos, M.H.; Vechetti, I.J., Jr; Veit, T.D.; Vella, L.J.; Velot, &#xC9;.; Verweij, F.J.; Vestad, B.; Vi&#xF1;as, J.L.; Visnovitz, T.; Vukman, K.V.; Wahlgren, J.; Watson, D.C.; Wauben, M.H.; Weaver, A.; Webber, J.P.; Weber, V.; Wehman, A.M.; Weiss, D.J.; Welsh, J.A.; Wendt, S.; Wheelock, A.M.; Wiener, Z.; Witte, L.; Wolfram, J.; Xagorari, A.; Xander, P.; Xu, J.; Yan, X.; Y&#xE1;&#xF1;ez-M&#xF3;, M.; Yin, H.; Yuana, Y.; Zappulli, V.; Zarubova, J.; &#x17D;\u0117kas, V.; Zhang, J.Y.; Zhao, Z.; Zheng, L.; Zheutlin, A.R.; Zickler, A.M.; Zim-mermann, P.; Zivkovic, A.M.; Zocco, D.; Zuba-Surma, E.K. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018,7(1),1535750","journal-title":"J Extracell Vesicles"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1242\/jcs.222406","volume":"132","author":"Latifkar A.","year":"2019","unstructured":"Latifkar A.; Hur Y.H.; Sanchez J.C.; Cerione R.A.; Antonyak M.A.; New insights into extracellular vesicle biogenesis and function. J Cell Sci 2019,132(13),132","journal-title":"J Cell Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0226-2","volume":"51","author":"G&#xE9;zsi A.","year":"2019","unstructured":"G&#xE9;zsi A.; Kov&#xE1;cs &#xC1;.; Visnovitz T.; Buz&#xE1;s E.I.; Systems biology approaches to investigating the roles of extracellular vesicles in human diseases. Exp Mol Med 2019,51(3),1-11","journal-title":"Exp Mol Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fphys.2019.00226","volume":"10","author":"Tang T.T.","year":"2019","unstructured":"Tang T.T.; Lv L.L.; Lan H.Y.; Liu B.C.; Extracellular vesicles: Opportunities and challenges for the treatment of renal diseases. Front Physiol 2019,10,226","journal-title":"Front Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCRESAHA.115.307654","volume":"118","author":"Kishore R.","year":"2016","unstructured":"Kishore R.; Khan M.; More than tiny sacks: Stem cell exosomes as cell-free modality for cardiac repair. Circ Res 2016,118(2),330-343","journal-title":"Circ Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","volume":"188","author":"Bebelman M.P.","year":"2018","unstructured":"Bebelman M.P.; Smit M.J.; Pegtel D.M.; Baglio S.R.; Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther 2018,188,1-11","journal-title":"Pharmacol Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","volume":"8","author":"Tricarico C.","year":"2017","unstructured":"Tricarico C.; Clancy J.; D\u2019Souza-Schorey C.; Biology and biogenesis of shed microvesicles. Small GTPases 2017,8(4),220-232","journal-title":"Small GTPases"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e1001450","DOI":"10.1371\/journal.pbio.1001450","volume":"10","author":"Kalra H.","year":"2012","unstructured":"Kalra H.; Simpson R.J.; Ji H.; Aikawa E.; Altevogt P.; Askenase P.; Bond V.C.; Borr&#xE0;s F.E.; Breakefield X.; Budnik V.; Buzas E.; Camussi G.; Clayton A.; Cocucci E.; Falcon-Perez J.M.; Gabrielsson S.; Gho Y.S.; Gupta D.; Harsha H.C.; Hendrix A.; Hill A.F.; In-al J.M.; Jenster G.; Kr&#xE4;mer-Albers E.M.; Lim S.K.; Llorente A.; L&#xF6;tvall J.; Marcilla A.; Mincheva-Nilsson L.; Nazarenko I.; Nieu-wland R.; Nolte-\u2019t Hoen E.N.; Pandey A.; Patel T.; Piper M.G.; Pluchino S.; Prasad T.S.; Rajendran L.; Raposo G.; Record M.; Reid G.E.; S&#xE1;nchez-Madrid F.; Schiffelers R.M.; Siljander P.; Stensballe A.; Stoorvogel W.; Taylor D.; Thery C.; Valadi H.; van Balkom B.W.; V&#xE1;zquez J.; Vidal M.; Wauben M.H.; Y&#xE1;&#xF1;ez-M&#xF3; M.; Zoeller M.; Mathivanan S.; Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012,10(12),e1001450","journal-title":"PLoS Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","year":"2013","unstructured":"EL Andaloussi, S.; M&#xE4;ger, I.; Breakefield, X.O.; Wood, M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013,12(5),347-357","journal-title":"Nat Rev Drug Discov"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1590\/1414-431X20132964","volume":"46","author":"Borges F.T.","year":"2013","unstructured":"Borges F.T.; Reis L.A.; Schor N.; Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res 2013,46(10),824-830","journal-title":"Braz J Med Biol Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/1878-0261.12144","volume":"11","author":"Bayraktar R.","year":"2017","unstructured":"Bayraktar R.; Van Roosbroeck K.; Calin G.A.; Cell-to-cell communication: microRNAs as hormones. Mol Oncol 2017,11(12),1673-1686","journal-title":"Mol Oncol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s004280050272","volume":"433","author":"Ihara T.","year":"1998","unstructured":"Ihara T.; Yamamoto T.; Sugamata M.; Okumura H.; Ueno Y.; The process of ultrastructural changes from nuclei to apoptotic body. Virchows Arch 1998,433(5),443-447","journal-title":"Virchows Arch"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells8070727","volume":"8","author":"Doyle L.M.","year":"2019","unstructured":"Doyle L.M.; Wang M.Z.; Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 2019,8(7),8","journal-title":"Cells"},{"key":"ref=59","first-page":"968","volume":"9","author":"Mettinger K.L.","year":"2018","unstructured":"Mettinger K.L.; Rameshwar P.; Kumar V.; Exosomes, Stem Cells\nand MicroRNA. In: Aging, Cancer Age Related Disorders Springer2018,9(8),968","journal-title":"Aging, Cancer Age Related Disorders"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7554\/eLife.47544","volume":"8","author":"Temoche-Diaz M.M.","year":"2019","unstructured":"Temoche-Diaz M.M.; Shurtleff M.J.; Nottingham R.M.; Yao J.; Fadadu R.P.; Lambowitz A.M.; Schekman R.; Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes. eLife 2019,8,8","journal-title":"eLife"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"161393","DOI":"10.1155\/2015\/161393","volume":"2015","author":"Pfeifer P.","year":"2015","unstructured":"Pfeifer P.; Werner N.; Jansen F.; Role and function of microRNAs in extracellular vesicles in cardiovascular biology. BioMed Res Int 2015,2015,161393","journal-title":"BioMed Res Int"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e0126423","DOI":"10.1371\/journal.pone.0126423","volume":"10","author":"Denk J.","year":"2015","unstructured":"Denk J.; Boelmans K.; Siegismund C.; Lassner D.; Arlt S.; Jahn H.; MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer\u2019s disease. PLoS One 2015,10(5),e0126423","journal-title":"PLoS One"},{"key":"ref=63","author":"Ceafalan L.C.","year":"2019","unstructured":"Ceafalan L.C.; Ioghen O.C.; Marta D.S.; Constantin A.; Alexandru N.; Nemecz M.; Tanko G.; Filippi A.; Magda S.L.; Bojin F.; Paunescu V.; Vinereanu D.; Georgescu A.; Gherghiceanu M.;  Part two: Extracellular vesicles as a risk factor in neurodegenerative dis-eases 2019","journal-title":"Part two: Extracellular vesicles as a risk factor in neurodegenerative dis-eases"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fnmol.2017.00276","volume":"10","author":"Ciregia F.","year":"2017","unstructured":"Ciregia F.; Urbani A.; Palmisano G.; Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases. Front Mol Neurosci 2017,10,276","journal-title":"Front Mol Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/ijms20020434","volume":"20","author":"Caruso Bavisotto C.","year":"2019","unstructured":"Caruso Bavisotto C.; Scalia F.; Marino Gammazza A.; Carlisi D.; Bucchieri F.; Conway de Macario E.; Macario A.J.L.; Cappello F.; Campanella C.; Extracellular Vesicle-Mediated Cell(-) Cell Communication in the Nervous System: Focus on Neurological Diseases. Int J Mol Sci 2019,20(2),434","journal-title":"Int J Mol Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/cne.901810108","volume":"181","author":"Peters A.","year":"1978","unstructured":"Peters A.; Fair&#xE9;n A.; Smooth and sparsely-spined stellate cells in the visual cortex of the rat: a study using a combined Golgi-electron microscopic technique. J Comp Neurol 1978,181(1),129-171","journal-title":"J Comp Neurol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/glia.20848","volume":"57","author":"Blackburn D.","year":"2009","unstructured":"Blackburn D.; Sargsyan S.; Monk P.N.; Shaw P.J.; Astrocyte function and role in motor neuron disease: a future therapeutic target? Glia 2009,57(12),1251-1264","journal-title":"Glia"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0192623310385254","volume":"39","author":"Sidoryk-Wegrzynowicz M.","year":"2011","unstructured":"Sidoryk-Wegrzynowicz M.; Wegrzynowicz M.; Lee E.; Bowman A.B.; Aschner M.; Role of astrocytes in brain function and disease. Toxicol Pathol 2011,39(1),115-123","journal-title":"Toxicol Pathol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrn3898","volume":"16","author":"Sofroniew M.V.","year":"2015","unstructured":"Sofroniew M.V.; Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci 2015,16(5),249-263","journal-title":"Nat Rev Neurosci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00702-014-1240-0","volume":"121","author":"Agnati L.F.","year":"2014","unstructured":"Agnati L.F.; Guidolin D.; Maura G.; Marcoli M.; Leo G.; Carone C.; De Caro R.; Genedani S.; Borroto-Escuela D.O.; Fuxe K.; Infor-mation handling by the brain: proposal of a new &#x201C;paradigm&#x201D; involving the roamer type of volume transmission and the tunneling nanotube type of wiring transmission. J Neural Transm (Vienna) 2014,121(12),1431-1449","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00702-009-0288-8","volume":"117","author":"Guescini M.","year":"2010","unstructured":"Guescini M.; Genedani S.; Stocchi V.; Agnati L.F.; Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm (Vienna) 2010,117(1),1-4","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fncel.2018.00526","volume":"12","author":"Pascua-Maestro R.","year":"2019","unstructured":"Pascua-Maestro R.; Gonz&#xE1;lez E.; Lillo C.; Ganfornina M.D.; Falc&#xF3;n-P&#xE9;rez J.M.; Sanchez D.; Extracellular vesicles secreted by astroglial cells transport apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front Cell Neurosci 2019,12,526","journal-title":"Front Cell Neurosci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/dneu.20559","volume":"67","author":"Taylor A.R.","year":"2007","unstructured":"Taylor A.R.; Robinson M.B.; Gifondorwa D.J.; Tytell M.; Milligan C.E.; Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev Neurobiol 2007,67(13),1815-1829","journal-title":"Dev Neurobiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"21384","DOI":"10.1074\/jbc.M112.340513","volume":"287","author":"Wang G.","year":"2012","unstructured":"Wang G.; Dinkins M.; He Q.; Zhu G.; Poirier C.; Campbell A.; Mayer-Proschel M.; Bieberich E.; Astrocytes secrete exosomes en-riched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 2012,287(25),21384-21395","journal-title":"J Biol Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fnins.2017.00335","volume":"11","author":"Willis C.M.","year":"2017","unstructured":"Willis C.M.; M&#xE9;noret A.; Jellison E.R.; Nicaise A.M.; Vella A.T.; Crocker S.J.; A refined bead-free method to identify astrocytic exo-somes in primary glial cultures and blood plasma. Front Neurosci 2017,11,335","journal-title":"Front Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fphar.2019.01452","volume":"10","author":"Venturini A.","year":"2019","unstructured":"Venturini A.; Passalacqua M.; Pelassa S.; Pastorino F.; Tedesco M.; Cortese K.; Gagliani M.C.; Leo G.; Maura G.; Guidolin D.; Ag-nati L.F.; Marcoli M.; Cervetto C.; Exosomes from astrocyte processes: Signaling to neurons. Front Pharmacol 2019,10,1452","journal-title":"Front Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fncel.2013.00251","volume":"7","author":"Gosselin R.D.","year":"2013","unstructured":"Gosselin R.D.; Meylan P.; Decosterd I.; Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation. Front Cell Neurosci 2013,7,251","journal-title":"Front Cell Neurosci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/glia.22963","volume":"64","author":"Guitart K.","year":"2016","unstructured":"Guitart K.; Loers G.; Buck F.; Bork U.; Schachner M.; Kleene R.; Improvement of neuronal cell survival by astrocyte-derived exo-somes under hypoxic and ischemic conditions depends on prion protein. Glia 2016,64(6),896-910","journal-title":"Glia"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells8111424","volume":"8","author":"Kuhn S.","year":"2019","unstructured":"Kuhn S.; Gritti L.; Crooks D.; Dombrowski Y.; Oligodendrocytes in development, myelin generation and beyond. Cells 2019,8(11),8","journal-title":"Cells"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fcell.2016.00079","volume":"4","author":"Domingues H.S.","year":"2016","unstructured":"Domingues H.S.; Portugal C.C.; Socodato R.; Relvas J.B.; Corrigendum: Oligodendrocyte, astrocyte and microglia crosstalk in myelin development, damage, and repair. Front Cell Dev Biol 2016,4,79","journal-title":"Front Cell Dev Biol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"e1001604","DOI":"10.1371\/journal.pbio.1001604","volume":"11","author":"Fr&#xFC;hbeis C.","year":"2013","unstructured":"Fr&#xFC;hbeis C.; Fr&#xF6;hlich D.; Kuo W.P.; Amphornrat J.; Thilemann S.; Saab A.S.; Kirchhoff F.; M&#xF6;bius W.; Goebbels S.; Nave K.A.; Schneider A.; Simons M.; Klugmann M.; Trotter J.; Kr&#xE4;mer-Albers E.M.; Neurotransmitter-triggered transfer of exosomes mediates oli-godendrocyte-neuron communication. PLoS Biol 2013,11(7),e1001604","journal-title":"PLoS Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1098\/rstb.2013.0510","volume":"369","author":"Fr&#xF6;hlich D.","year":"2014","unstructured":"Fr&#xF6;hlich D.; Kuo W.P.; Fr&#xFC;hbeis C.; Sun J.J.; Zehendner C.M.; Luhmann H.J.; Pinto S.; Toedling J.; Trotter J.; Kr&#xE4;mer-Albers E.M.; Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos Trans R Soc Lond B Biol Sci 2014,369(1652),369","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=83","first-page":"2019.12.20.884171","author":"Fr&#xFC;hbeis C.","year":"2019","unstructured":"Fr&#xFC;hbeis C.; Kuo-Elsner W.P.; Barth K.; Peris L.; Tenzer S.; M&#xF6;bius W.; Werner H.B.; Nave K-A.; Fr&#xF6;hlich D.; Kr&#xE4;mer-Albers E-M.; Oligodendrocyte-derived exosomes promote axonal transport and axonal long-term maintenance bioRxiv 2019,2019.12.20.884171","journal-title":"bioRxiv"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.tins.2019.02.007","volume":"42","author":"Delpech J.C.","year":"2019","unstructured":"Delpech J.C.; Herron S.; Botros M.B.; Ikezu T.; Neuroimmune crosstalk through extracellular vesicles in health and disease. Trends Neurosci 2019,42(5),361-372","journal-title":"Trends Neurosci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"5150678","DOI":"10.1155\/2017\/5150678","volume":"2017","author":"Yin J.","year":"2017","unstructured":"Yin J.; Valin K.L.; Dixon M.L.; Leavenworth J.W.; The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer. J Immunol Res 2017,2017,5150678","journal-title":"J Immunol Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nn.3358","volume":"16","author":"Ueno M.","year":"2013","unstructured":"Ueno M.; Fujita Y.; Tanaka T.; Nakamura Y.; Kikuta J.; Ishii M.; Yamashita T.; Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 2013,16(5),543-551","journal-title":"Nat Neurosci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/glia.22772","volume":"63","author":"Glebov K.","year":"2015","unstructured":"Glebov K.; L&#xF6;chner M.; Jabs R.; Lau T.; Merkel O.; Schloss P.; Steinh&#xE4;user C.; Walter J.; Serotonin stimulates secretion of exosomes from microglia cells. Glia 2015,63(4),626-634","journal-title":"Glia"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.4049\/jimmunol.175.4.2237","volume":"175","author":"Potolicchio I.","year":"2005","unstructured":"Potolicchio I.; Carven G.J.; Xu X.; Stipp C.; Riese R.J.; Stern L.J.; Santambrogio L.; Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol 2005,175(4),2237-2243","journal-title":"J Immunol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fphar.2017.00910","volume":"8","author":"Drago F.","year":"2017","unstructured":"Drago F.; Lombardi M.; Prada I.; Gabrielli M.; Joshi P.; Cojoc D.; Franck J.; Fournier I.; Vizioli J.; Verderio C.; ATP modifies the proteome of extracellular vesicles released by microglia and influences their action on astrocytes. Front Pharmacol 2017,8,910","journal-title":"Front Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.mcn.2005.12.003","volume":"31","author":"Faur&#xE9; J.","year":"2006","unstructured":"Faur&#xE9; J.; Lachenal G.; Court M.; Hirrlinger J.; Chatellard-Causse C.; Blot B.; Grange J.; Schoehn G.; Goldberg Y.; Boyer V.; Kirch-hoff F.; Raposo G.; Garin J.; Sadoul R.; Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 2006,31(4),642-648","journal-title":"Mol Cell Neurosci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.mcn.2010.11.004","volume":"46","author":"Lachenal G.","year":"2011","unstructured":"Lachenal G.; Pernet-Gallay K.; Chivet M.; Hemming F.J.; Belly A.; Bodon G.; Blot B.; Haase G.; Goldberg Y.; Sadoul R.; Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 2011,46(2),409-418","journal-title":"Mol Cell Neurosci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1073\/pnas.1902513116","volume":"116","author":"Sharma P.","year":"2019","unstructured":"Sharma P.; Mesci P.; Carromeu C.; McClatchy D.R.; Schiapparelli L.; Yates J.R.; Muotri A.R.; Cline H.T.; Exosomes regulate neu-rogenesis and circuit assembly. Proc Natl Acad Sci USA 2019,116(32),16086-16094","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"7989","DOI":"10.1038\/srep07989","volume":"5","author":"Bahrini I.","year":"2015","unstructured":"Bahrini I.; Song J.H.; Diez D.; Hanayama R.; Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci Rep 2015,5,7989","journal-title":"Sci Rep"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20071728","volume":"20","author":"Lee S.","year":"2019","unstructured":"Lee S.; Mankhong S.; Kang J.H.; Extracellular vesicle as a source of Alzheimer\u2019s biomarkers: Opportunities and challenges. Int J Mol Sci 2019,20(7),20","journal-title":"Int J Mol Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"Corder E.H.","year":"1993","unstructured":"Corder E.H.; Saunders A.M.; Strittmatter W.J.; Schmechel D.E.; Gaskell P.C.; Small G.W.; Roses A.D.; Haines J.L.; Pericak-Vance M.A.; Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 1993,261(5123),921-923","journal-title":"Science"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"Farrer L.A.","year":"1997","unstructured":"Farrer L.A.; Cupples L.A.; Haines J.L.; Hyman B.; Kukull W.A.; Mayeux R.; Myers R.H.; Pericak-Vance M.A.; Risch N.; van Duijn C.M.; Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 1997,278(16),1349-1356","journal-title":"JAMA"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"Rajendran L.","year":"2006","unstructured":"Rajendran L.; Honsho M.; Zahn T.R.; Keller P.; Geiger K.D.; Verkade P.; Simons K.; Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA 2006,103(30),11172-11177","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1096\/fj.07-9357com","volume":"22","author":"Sharples R.A.","year":"2008","unstructured":"Sharples R.A.; Vella L.J.; Nisbet R.M.; Naylor R.; Perez K.; Barnham K.J.; Masters C.L.; Hill A.F.; Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J 2008,22(5),1469-1478","journal-title":"FASEB J"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"Asai H.","year":"2015","unstructured":"Asai H.; Ikezu S.; Tsunoda S.; Medalla M.; Luebke J.; Haydar T.; Wolozin B.; Butovsky O.; K&#xFC;gler S.; Ikezu T.; Depletion of micro-glia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 2015,18(11),1584-1593","journal-title":"Nat Neurosci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"Dinkins M.B.","year":"2014","unstructured":"Dinkins M.B.; Dasgupta S.; Wang G.; Zhu G.; Bieberich E.; Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 2014,35(8),1792-1800","journal-title":"Neurobiol Aging"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"Serrano-Pozo A.","year":"2011","unstructured":"Serrano-Pozo A.; Mielke M.L.; G&#xF3;mez-Isla T.; Betensky R.A.; Growdon J.H.; Frosch M.P.; Hyman B.T.; Reactive glia not only associ-ates with plaques but also parallels tangles in Alzheimer\u2019s disease. Am J Pathol 2011,179(3),1373-1384","journal-title":"Am J Pathol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"9477","DOI":"10.1038\/s41598-019-45676-0","volume":"9","author":"Crotti A.","year":"2019","unstructured":"Crotti A.; Sait H.R.; McAvoy K.M.; Estrada K.; Ergun A.; Szak S.; Marsh G.; Jandreski L.; Peterson M.; Reynolds T.L.; Dalkilic-Liddle I.; Cameron A.; Cahir-McFarland E.; Ransohoff R.M.; BIN1 favors the spreading of Tau via extracellular vesicles. Sci Rep 2019,9(1),9477","journal-title":"Sci Rep"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-2010-091603","volume":"21","author":"Nelson P.T.","year":"2010","unstructured":"Nelson P.T.; Wang W.X.; MiR-107 is reduced in Alzheimer\u2019s disease brain neocortex: validation study. J Alzheimers Dis 2010,21(1),75-79","journal-title":"J Alzheimers Dis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","volume":"88","author":"Zhu H.C.","year":"2012","unstructured":"Zhu H.C.; Wang L.M.; Wang M.; Song B.; Tan S.; Teng J.F.; Duan D.X.; MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-&#x3B2; production by targeting BACE1. Brain Res Bull 2012,88(6),596-601","journal-title":"Brain Res Bull"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.expneurol.2011.11.010","volume":"235","author":"Kim J.","year":"2012","unstructured":"Kim J.; Yoon H.; Ram&#xED;rez C.M.; Lee S.M.; Hoe H.S.; Fern&#xE1;ndez-Hernando C.; Kim J.; MiR-106b impairs cholesterol efflux and in-creases A&#x3B2; levels by repressing ABCA1 expression. Exp Neurol 2012,235(2),476-483","journal-title":"Exp Neurol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/jnc.13573","volume":"137","author":"Ben Halima S.","year":"2016","unstructured":"Ben Halima S.; Siegel G.; Rajendran L.; miR-186 in Alzheimer\u2019s disease: a big hope for a small RNA? J Neurochem 2016,137(3),308-311","journal-title":"J Neurochem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1326-3-10","volume":"3","author":"Patel N.","year":"2008","unstructured":"Patel N.; Hoang D.; Miller N.; Ansaloni S.; Huang Q.; Rogers J.T.; Lee J.C.; Saunders A.J.; MicroRNAs can regulate human APP lev-els. Mol Neurodegener 2008,3,10","journal-title":"Mol Neurodegener"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"Yang L.B.","year":"2003","unstructured":"Yang L.B.; Lindholm K.; Yan R.; Citron M.; Xia W.; Yang X.L.; Beach T.; Sue L.; Wong P.; Price D.; Li R.; Shen Y.; Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003,9(1),3-4","journal-title":"Nat Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"Cogswell J.P.","year":"2008","unstructured":"Cogswell J.P.; Ward J.; Taylor I.A.; Waters M.; Shi Y.; Cannon B.; Kelnar K.; Kemppainen J.; Brown D.; Chen C.; Prinjha R.K.; Richardson J.C.; Saunders A.M.; Roses A.D.; Richards C.A.; Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008,14(1),27-41","journal-title":"J Alzheimers Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2009.04.052","volume":"459","author":"Sethi P.","year":"2009","unstructured":"Sethi P.; Lukiw W.J.; Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer\u2019s disease temporal lobe neo-cortex. Neurosci Lett 2009,459(2),100-104","journal-title":"Neurosci Lett"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"e11070","DOI":"10.1371\/journal.pone.0011070","volume":"5","author":"Schonrock N.","year":"2010","unstructured":"Schonrock N.; Ke Y.D.; Humphreys D.; Staufenbiel M.; Ittner L.M.; Preiss T.; G&#xF6;tz J.; Neuronal microRNA deregulation in response to Alzheimer\u2019s disease amyloid-beta. PLoS One 2010,5(6),e11070","journal-title":"PLoS One"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fncel.2013.00220","volume":"7","author":"Coolen M.","year":"2013","unstructured":"Coolen M.; Katz S.; Bally-Cuif L.; miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 2013,7,220","journal-title":"Front Cell Neurosci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12031-011-9587-2","volume":"46","author":"Schonrock N.","year":"2012","unstructured":"Schonrock N.; Humphreys D.T.; Preiss T.; G&#xF6;tz J.; Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-&#x3B2;. J Mol Neurosci 2012,46(2),324-335","journal-title":"J Mol Neurosci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","volume":"78","author":"Mairet-Coello G.","year":"2013","unstructured":"Mairet-Coello G.; Courchet J.; Pieraut S.; Courchet V.; Maximov A.; Polleux F.; The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of A&#x3B2; oligomers through Tau phosphorylation. Neuron 2013,78(1),94-108","journal-title":"Neuron"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/gb-2006-7-9-r85","volume":"7","author":"Wu J.","year":"2006","unstructured":"Wu J.; Xie X.; Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol 2006,7(9),R85","journal-title":"Genome Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3892\/mmr.2014.2013","volume":"9","author":"Chang F.","year":"2014","unstructured":"Chang F.; Zhang L.H.; Xu W.P.; Jing P.; Zhan P.Y.; microRNA-9 attenuates amyloid&#x3B2;-induced synaptotoxicity by targeting calci-um\/calmodulin-dependent protein kinase kinase 2. Mol Med Rep 2014,9(5),1917-1922","journal-title":"Mol Med Rep"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"Wang W.X.","year":"2008","unstructured":"Wang W.X.; Rajeev B.W.; Stromberg A.J.; Ren N.; Tang G.; Huang Q.; Rigoutsos I.; Nelson P.T.; The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor pro-tein-cleaving enzyme 1. J Neurosci 2008,28(5),1213-1223","journal-title":"J Neurosci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2350-13-35","volume":"13","author":"Augustin R.","year":"2012","unstructured":"Augustin R.; Endres K.; Reinhardt S.; Kuhn P.H.; Lichtenthaler S.F.; Hansen J.; Wurst W.; Tr&#xFC;mbach D.; Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet 2012,13,35","journal-title":"BMC Med Genet"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"e15546","DOI":"10.1371\/journal.pone.0015546","volume":"5","author":"Yao J.","year":"2010","unstructured":"Yao J.; Hennessey T.; Flynt A.; Lai E.; Beal M.F.; Lin M.T.; MicroRNA-related cofilin abnormality in Alzheimer\u2019s disease. PLoS One 2010,5(12),e15546","journal-title":"PLoS One"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"713","DOI":"10.7326\/0003-4819-145-10-200611210-00004","volume":"145","author":"Vickrey B.G.","year":"2006","unstructured":"Vickrey B.G.; Mittman B.S.; Connor K.I.; Pearson M.L.; Della Penna R.D.; Ganiats T.G.; Demonte R.W.; Chodosh J.; Cui X.; Vassar S.; Duan N.; Lee M.; The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Intern Med 2006,145(10),713-726","journal-title":"Ann Intern Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2165\/0002512-200926020-00005","volume":"26","author":"Voisin T.","year":"2009","unstructured":"Voisin T.; Vellas B.; Diagnosis and treatment of patients with severe Alzheimer\u2019s disease. Drugs Aging 2009,26(2),135-144","journal-title":"Drugs Aging"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"Emamzadeh F.N.","year":"2018","unstructured":"Emamzadeh F.N.; Surguchov A.; Parkinson\u2019s Disease: Biomarkers, Treatment, and Risk Factors. Front Neurosci 2018,12,612","journal-title":"Front Neurosci"},{"key":"ref=123","author":"Zafar S.","year":"2021","unstructured":"Zafar S.; Yaddanapudi S.S.; Parkinson Disease. StatPearls StatPearls Publishing, 2022 Jan-. Available from: 2021","journal-title":"StatPearls"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"Poewe W.","year":"2017","unstructured":"Poewe W.; Seppi K.; Tanner C.M.; Halliday G.M.; Brundin P.; Volkmann J.; Schrag A.E.; Lang A.E.; Parkinson disease. Nat Rev Dis Primers 2017,3,17013","journal-title":"Nat Rev Dis Primers"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"El-Agnaf O.M.","year":"2003","unstructured":"El-Agnaf O.M.; Salem S.A.; Paleologou K.E.; Cooper L.J.; Fullwood N.J.; Gibson M.J.; Curran M.D.; Court J.A.; Mann D.M.; Ikeda S.; Cookson M.R.; Hardy J.; Allsop D.; Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, in-cluding human plasma. FASEB J 2003,17(13),1945-1947","journal-title":"FASEB J"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"Emmanouilidou E.","year":"2010","unstructured":"Emmanouilidou E.; Melachroinou K.; Roumeliotis T.; Garbis S.D.; Ntzouni M.; Margaritis L.H.; Stefanis L.; Vekrellis K.; Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010,30(20),6838-6851","journal-title":"J Neurosci"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"Alvarez-Erviti L.","year":"2011","unstructured":"Alvarez-Erviti L.; Seow Y.; Schapira A.H.; Gardiner C.; Sargent I.L.; Wood M.J.; Cooper J.M.; Lysosomal dysfunction increases exo-some-mediated alpha-synuclein release and transmission. Neurobiol Dis 2011,42(3),360-367","journal-title":"Neurobiol Dis"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"Danzer K.M.","year":"2012","unstructured":"Danzer K.M.; Kranich L.R.; Ruf W.P.; Cagsal-Getkin O.; Winslow A.R.; Zhu L.; Vanderburg C.R.; McLean P.J.; Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 2012,7,42","journal-title":"Mol Neurodegener"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Cao Z.","year":"2019","unstructured":"Cao Z.; Wu, Y.; Liu, G.; Jiang, Y.; Wang, X.; Wang, Z.; Feng, T. &#x3B1;-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 2019,696,114-120","journal-title":"Neurosci Lett"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neulet.2013.06.009","volume":"548","author":"Chang C.","year":"2013","unstructured":"Chang C.; Lang H.; Geng N.; Wang J.; Li N.; Wang X.; Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Neurosci Lett 2013,548,190-195","journal-title":"Neurosci Lett"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"Cooper J.M.","year":"2014","unstructured":"Cooper J.M.; Wiklander P.B.; Nordin J.Z.; Al-Shawi R.; Wood M.J.; Vithlani M.; Schapira A.H.; Simons J.P.; El-Andaloussi S.; Alva-rez-Erviti, L. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 2014,29(12),1476-1485","journal-title":"Mov Disord"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"Haney M.J.","year":"2015","unstructured":"Haney M.J.; Klyachko N.L.; Zhao Y.; Gupta R.; Plotnikova E.G.; He Z.; Patel T.; Piroyan A.; Sokolsky M.; Kabanov A.V.; Batrako-va E.V.; Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 2015,207,18-30","journal-title":"J Control Release"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","volume":"717","author":"Etheridge A.","year":"2011","unstructured":"Etheridge A.; Lee I.; Hood L.; Galas D.; Wang K.; Extracellular microRNA: a new source of biomarkers. Mutat Res 2011,717(1-2),85-90","journal-title":"Mutat Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/1871527314666150225143637","volume":"14","author":"Kamal M.A.","year":"2015","unstructured":"Kamal M.A.; Mushtaq G.; Greig N.H.; Current update on synopsis of miRNA dysregulation in neurological disorders. CNS Neurol Disord Drug Targets 2015,14(4),492-501","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fgene.2014.00054","volume":"5","author":"Palanichamy J.K.","year":"2014","unstructured":"Palanichamy J.K.; Rao D.S.; miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet 2014,5,54","journal-title":"Front Genet"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20225649","volume":"20","author":"Goh S.Y.","year":"2019","unstructured":"Goh S.Y.; Chao Y.X.; Dheen S.T.; Tan E.K.; Tay S.S.; Role of MicroRNAs in Parkinson\u2019s Disease. Int J Mol Sci 2019,20(22),20","journal-title":"Int J Mol Sci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","volume":"20","author":"Mi&#xF1;ones-Moyano E.","year":"2011","unstructured":"Mi&#xF1;ones-Moyano E.; Porta S.; Escaram&#xED;s G.; Rabionet R.; Iraola S.; Kagerbauer B.; Espinosa-Parrilla Y.; Ferrer I.; Estivill X.; Mart&#xED; E.; MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial func-tion. Hum Mol Genet 2011,20(15),3067-3078","journal-title":"Hum Mol Genet"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"a009415","DOI":"10.1101\/cshperspect.a009415","volume":"2","author":"Cookson M.R.","year":"2012","unstructured":"Cookson M.R.; Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb Perspect Med 2012,2(9),a009415","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"Shimura H.","year":"2000","unstructured":"Shimura H.; Hattori N.; Kubo Si.; Mizuno Y.; Asakawa S.; Minoshima S.; Shimizu N.; Iwai K.; Chiba T.; Tanaka K.; Suzuki T.; Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000,25(3),302-305","journal-title":"Nat Genet"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/mds.10467","volume":"18","author":"Illarioshkin S.N.","year":"2003","unstructured":"Illarioshkin S.N.; Periquet M.; Rawal N.; L&#xFC;cking C.B.; Zagorovskaya T.B.; Slominsky P.A.; Miloserdova O.V.; Markova E.D.; Lim-borska S.A.; Ivanova-Smolenskaya I.A.; Brice A.; Mutation analysis of the parkin gene in Russian families with autosomal recessive ju-venile parkinsonism. Mov Disord 2003,18(8),914-919","journal-title":"Mov Disord"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1523\/JNEUROSCI.2600-15.2015","volume":"35","author":"Lindberg I.","year":"2015","unstructured":"Lindberg I.; Shorter J.; Wiseman R.L.; Chiti F.; Dickey C.A.; McLean P.J.; Chaperones in Neurodegeneration. J Neurosci 2015,35(41),13853-13859","journal-title":"J Neurosci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"Auluck P.K.","year":"2002","unstructured":"Auluck P.K.; Chan H.Y.; Trojanowski J.Q.; Lee V.M.; Bonini N.M.; Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson\u2019s disease. Science 2002,295(5556),865-868","journal-title":"Science"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"25497","DOI":"10.1074\/jbc.M400255200","volume":"279","author":"Klucken J.","year":"2004","unstructured":"Klucken J.; Shin Y.; Masliah E.; Hyman B.T.; McLean P.J.; Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity. J Biol Chem 2004,279(24),25497-25502","journal-title":"J Biol Chem"},{"key":"ref=144","first-page":"938348","volume":"2014","author":"Zhang Z.","year":"2014","unstructured":"Zhang Z.; Cheng Y.; miR-16-1 promotes the aberrant &#x3B1;-synuclein accumulation in parkinson disease via targeting heat shock protein 70. Sci World J 2014,2014,938348","journal-title":"Sci World J"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1038\/cddis.2013.73","volume":"4","author":"Alvarez-Erviti L.","year":"2013","unstructured":"Alvarez-Erviti L.; Seow Y.; Schapira A.H.; Rodriguez-Oroz M.C.; Obeso J.A.; Cooper J.M.; Influence of microRNA deregulation on chaperone-mediated autophagy and &#x3B1;-synuclein pathology in Parkinson\u2019s disease. Cell Death Dis 2013,4,e545","journal-title":"Cell Death Dis"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"Kim J.","year":"2007","unstructured":"Kim J.; Inoue K.; Ishii J.; Vanti W.B.; Voronov S.V.; Murchison E.; Hannon G.; Abeliovich A.; A MicroRNA feedback circuit in mid-brain dopamine neurons. Science 2007,317(5842),1220-1224","journal-title":"Science"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1743-422X-8-559","volume":"8","author":"Imran M.","year":"2011","unstructured":"Imran M.; Mahmood S.; An overview of human prion diseases. Virol J 2011,8,559","journal-title":"Virol J"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.pmbts.2019.05.005","volume":"166","author":"Avni A.","year":"2019","unstructured":"Avni A.; Swasthi H.M.; Majumdar A.; Mukhopadhyay S.; Intrinsically disordered proteins in the formation of functional amyloids from bacteria to humans. Prog Mol Biol Transl Sci 2019,166,109-143","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00002093-198903010-00002","volume":"3","author":"Creutzfeldt H.G.","year":"1989","unstructured":"Creutzfeldt H.G.; On a particular focal disease of the central nervous system (preliminary communication), 1920. Alzheimer Dis Assoc Disord 1989,3(1-2),3-25","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1076\/jhin.8.1.21.1771","volume":"8","author":"Duckett S.","year":"1999","unstructured":"Duckett S.; Stern J.; Origins of the Creutzfeldt and Jakob concept. J Hist Neurosci 1999,8(1),21-34","journal-title":"J Hist Neurosci"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/bmb\/66.1.267","volume":"66","author":"K&#xFC;bler E.","year":"2003","unstructured":"K&#xFC;bler E.; Oesch B.; Raeber A.J.; Diagnosis of prion diseases. Br Med Bull 2003,66,267-279","journal-title":"Br Med Bull"},{"key":"ref=152","first-page":"320","volume":"49","author":"Puckett C.","year":"1991","unstructured":"Puckett C.; Concannon P.; Casey C.; Hood L.; Genomic structure of the human prion protein gene. Am J Hum Genet 1991,49(2),320-329","journal-title":"Am J Hum Genet"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.12688\/f1000research.12681.1","volume":"6","author":"Mackenzie G.","year":"2017","unstructured":"Mackenzie G.; Will R.; Creutzfeldt-Jakob disease: recent developments. F1000 Res 2017,6,2053","journal-title":"F1000 Res"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40249-016-0143-8","volume":"5","author":"Chen C.","year":"2016","unstructured":"Chen C.; Dong X.P.; Epidemiological characteristics of human prion diseases. Infect Dis Poverty 2016,5(1),47","journal-title":"Infect Dis Poverty"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.1083320","volume":"300","author":"Mead S.","year":"2003","unstructured":"Mead S.; Stumpf M.P.; Whitfield J.; Beck J.A.; Poulter M.; Campbell T.; Uphill J.B.; Goldstein D.; Alpers M.; Fisher E.M.; Collinge J.; Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 2003,300(5619),640-643","journal-title":"Science"},{"key":"ref=156","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000251","volume":"21","author":"Geschwind M.D.","year":"2015","unstructured":"Geschwind M.D.; Prion Diseases. Continuum (Minneap Minn) (6 Neuroinfectious Disease), 1612-1638.2015,21","journal-title":"Continuum (Minneap Minn)"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/brain\/96.1.1","volume":"96","author":"Roos R.","year":"1973","unstructured":"Roos R.; Gajdusek D.C.; Gibbs C.J.; The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 1973,96(1),1-20","journal-title":"Brain"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/brain\/104.3.559","volume":"104","author":"Masters C.L.","year":"1981","unstructured":"Masters C.L.; Gajdusek D.C.; Gibbs C.J.; Jr Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Str&#xE4;ussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981,104(3),559-588","journal-title":"Brain"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"a006833","DOI":"10.1101\/cshperspect.a006833","volume":"3","author":"Colby D.W.","year":"2011","unstructured":"Colby D.W.; Prusiner S.B.; Prions. Cold Spring Harb Perspect Biol 2011,3(1),a006833","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"Prusiner S.B.","year":"1998","unstructured":"Prusiner S.B.; Prions. Proc Natl Acad Sci USA 1998,95(23),13363-13383","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrn2037","volume":"7","author":"Kosik K.S.","year":"2006","unstructured":"Kosik K.S.; The neuronal microRNA system. Nat Rev Neurosci 2006,7(12),911-920","journal-title":"Nat Rev Neurosci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"e1006802","DOI":"10.1371\/journal.ppat.1006802","volume":"14","author":"Llorens F.","year":"2018","unstructured":"Llorens F.; Th&#xFC;ne K.; Mart&#xED; E.; Kanata E.; Dafou D.; D&#xED;az-Lucena D.; Vivancos A.; Shomroni O.; Zafar S.; Schmitz M.; Michel U.; Fern&#xE1;ndez-Borges N.; Andr&#xE9;oletti O.; Del R&#xED;o J.A.; D&#xED;ez J.; Fischer A.; Bonn S.; Sklaviadis T.; Torres J.M.; Ferrer I.; Zerr I.; Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing ma-chinery and biogenesis. PLoS Pathog 2018,14(1),e1006802","journal-title":"PLoS Pathog"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nsmb.2273","volume":"19","author":"Gibbings D.","year":"2012","unstructured":"Gibbings D.; Leblanc P.; Jay F.; Pontier D.; Michel F.; Schwab Y.; Alais S.; Lagrange T.; Voinnet O.; Human prion protein binds\nArgonaute and promotes accumulation of microRNA effector complexes. Nat Struct Mol Biol S1.2012,19(5),517-524","journal-title":"Nat Struct Mol Biol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"Lukiw W.J.","year":"2007","unstructured":"Lukiw W.J.; Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport 2007,18(3),297-300","journal-title":"Neuroreport"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"e25443","DOI":"10.1371\/journal.pone.0025443","volume":"6","author":"Martins M.","year":"2011","unstructured":"Martins M.; Rosa A.; Guedes L.C.; Fonseca B.V.; Gotovac K.; Violante S.; Mestre T.; Coelho M.; Rosa M.M.; Martin E.R.; Vance J.M.; Outeiro T.F.; Wang L.; Borovecki F.; Ferreira J.J.; Oliveira S.A.; Convergence of miRNA expression profiling, &#x3B1;-synuclein interac-ton and GWAS in Parkinson\u2019s disease. PLoS One 2011,6(10),e25443","journal-title":"PLoS One"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"10937","DOI":"10.1093\/nar\/gks832","volume":"40","author":"Bellingham S.A.","year":"2012","unstructured":"Bellingham S.A.; Coleman B.M.; Hill A.F.; Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 2012,40(21),10937-10949","journal-title":"Nucleic Acids Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mcn.2015.12.001","volume":"71","author":"Boese A.S.","year":"2016","unstructured":"Boese A.S.; Saba R.; Campbell K.; Majer A.; Medina S.; Burton L.; Booth T.F.; Chong P.; Westmacott G.; Dutta S.M.; Saba J.A.; Booth S.A.; MicroRNA abundance is altered in synaptoneurosomes during prion disease. Mol Cell Neurosci 2016,71,13-24","journal-title":"Mol Cell Neurosci"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/15287394.2011.618973","volume":"74","author":"Lukiw W.J.","year":"2011","unstructured":"Lukiw W.J.; Dua P.; Pogue A.I.; Eicken C.; Hill J.M.; Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neu-rodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J Toxicol Environ Health A 2011,74(22-24),1460-1468","journal-title":"J Toxicol Environ Health A"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-4-36","volume":"4","author":"Montag J.","year":"2009","unstructured":"Montag J.; Hitt R.; Opitz L.; Schulz-Schaeffer W.J.; Hunsmann G.; Motzkus D.; Upregulation of miRNA hsa-miR-342-3p in experi-mental and idiopathic prion disease. Mol Neurodegener 2009,4,36","journal-title":"Mol Neurodegener"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"e3652","DOI":"10.1371\/journal.pone.0003652","volume":"3","author":"Saba R.","year":"2008","unstructured":"Saba R.; Goodman C.D.; Huzarewich R.L.; Robertson C.; Booth S.A.; A miRNA signature of prion induced neurodegeneration. PLoS One 2008,3(11),e3652","journal-title":"PLoS One"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"e30832","DOI":"10.1371\/journal.pone.0030832","volume":"7","author":"Saba R.","year":"2012","unstructured":"Saba R.; Gushue S.; Huzarewich R.L.; Manguiat K.; Medina S.; Robertson C.; Booth S.A.; MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012,7(2),e30832","journal-title":"PLoS One"},{"key":"ref=172","author":"Vinken P.J.","year":"1968","unstructured":"Vinken P.J.; Bruyn G.W.; Klawans H.L.;  Handbook of clinical\nneurology North-Holland, c: Amsterdam1968","journal-title":"Handbook of clinical\nneurology"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"Myers R.H.","year":"2004","unstructured":"Myers R.H.; Huntington\u2019s disease genetics. NeuroRx 2004,1(2),255-262","journal-title":"NeuroRx"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"MacDonald M.E.","year":"1993","unstructured":"MacDonald M.E.; Ambrose C.M.; Duyao M.P.; Datson N.; Shaw D.; Harper P.S.; A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 1993,72(6),971-983","journal-title":"Cell"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"Duyao M.","year":"1993","unstructured":"Duyao M.; Ambrose C.; Myers R.; Novelletto A.; Persichetti F.; Frontali M.; Folstein S.; Ross C.; Franz M.; Abbott M.; Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 1993,4(4),387-392","journal-title":"Nat Genet"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2174\/1871527315666160922163511","volume":"15","author":"Wilson C.M.","year":"2016","unstructured":"Wilson C.M.; Mushtaq G.; Kamal M.A.; Terro F.; The Role of Endoproteolytic Processing in Neurodegeneration. CNS Neurol Disord Drug Targets 2016,15(10),1222-1230","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"Yamamoto A.","year":"2000","unstructured":"Yamamoto A.; Lucas J.J.; Hen R.; Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 2000,101(1),57-66","journal-title":"Cell"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"Hodges A.","year":"2006","unstructured":"Hodges A.; Strand A.D.; Aragaki A.K.; Kuhn A.; Sengstag T.; Hughes G.; Elliston L.A.; Hartog C.; Goldstein D.R.; Thu D.; Hol-lingsworth Z.R.; Collin F.; Synek B.; Holmans P.A.; Young A.B.; Wexler N.S.; Delorenzi M.; Kooperberg C.; Augood S.J.; Faull R.L.; Olson J.M.; Jones L.; Luthi-Carter R.; Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet 2006,15(6),965-977","journal-title":"Hum Mol Genet"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","volume":"27","author":"Zuccato C.","year":"2007","unstructured":"Zuccato C.; Belyaev N.; Conforti P.; Ooi L.; Tartari M.; Papadimou E.; MacDonald M.; Fossale E.; Zeitlin S.; Buckley N.; Cattaneo E.; Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease. J Neurosci 2007,27(26),6972-6983","journal-title":"J Neurosci"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"Zuccato C.","year":"2003","unstructured":"Zuccato C.; Tartari M.; Crotti A.; Goffredo D.; Valenza M.; Conti L.; Cataudella T.; Leavitt B.R.; Hayden M.R.; Timmusk T.; Riga-monti D.; Cattaneo E.; Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 2003,35(1),76-83","journal-title":"Nat Genet"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"Johnson R.","year":"2009","unstructured":"Johnson R.; Buckley N.J.; Gene dysregulation in Huntington\u2019s disease: REST, microRNAs and beyond. Neuromolecular Med 2009,11(3),183-199","journal-title":"Neuromolecular Med"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1261\/rna.1127009","volume":"15","author":"Johnson R.","year":"2009","unstructured":"Johnson R.; Teh C.H.; Jia H.; Vanisri R.R.; Pandey T.; Lu Z.H.; Buckley N.J.; Stanton L.W.; Lipovich L.; Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 2009,15(1),85-96","journal-title":"RNA"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"Mart&#xED; E.","year":"2010","unstructured":"Mart&#xED; E.; Pantano L.; Ba&#xF1;ez-Coronel M.; Llorens F.; Mi&#xF1;ones-Moyano E.; Porta S.; Sumoy L.; Ferrer I.; Estivill X.; A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 2010,38(20),7219-7235","journal-title":"Nucleic Acids Res"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fnagi.2018.00139","volume":"10","author":"Shah S.Z.A.","year":"2018","unstructured":"Shah S.Z.A.; Zhao D.; Hussain T.; Sabir N.; Yang L.; Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases. Front Aging Neurosci 2018,10,139","journal-title":"Front Aging Neurosci"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","volume":"227","author":"Lee S.T.","year":"2011","unstructured":"Lee S.T.; Chu K.; Im, W.S.; Yoon, H.J.; Im, J.Y.; Park, J.E.; Park, K.H.; Jung, K.H.; Lee, S.K.; Kim, M.; Roh, J.K. Altered microRNA regulation in Huntington\u2019s disease models. Exp Neurol 2011,227(1),172-179","journal-title":"Exp Neurol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"Kocerha J.","year":"2014","unstructured":"Kocerha J.; Xu Y.; Prucha M.S.; Zhao D.; Chan A.W.; microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys. Mol Brain 2014,7,46","journal-title":"Mol Brain"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"Johnson R.","year":"2008","unstructured":"Johnson R.; Zuccato C.; Belyaev N.D.; Guest D.J.; Cattaneo E.; Buckley N.J.; A microRNA-based gene dysregulation pathway in Hun-tington\u2019s disease. Neurobiol Dis 2008,29(3),438-445","journal-title":"Neurobiol Dis"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bbrc.2013.06.041","volume":"437","author":"Das E.","year":"2013","unstructured":"Das E.; Jana N.R.; Bhattacharyya N.P.; MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)\/Hdh(Q111) cells. Biochem Biophys Res Commun 2013,437(2),217-224","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"Rowland L.P.","year":"2001","unstructured":"Rowland L.P.; Shneider N.A.; Amyotrophic lateral sclerosis. N Engl J Med 2001,344(22),1688-1700","journal-title":"N Engl J Med"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jnnp.2009.188151","volume":"9","author":"Talbot K.","year":"2009","unstructured":"Talbot K.; Motor neuron disease: the bare essentials. Pract Neurol 2009,9(5),303-309","journal-title":"Pract Neurol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24096","volume":"75","author":"Pupillo E.","year":"2014","unstructured":"Pupillo E.; Messina P.; Logroscino G.; Beghi E.; Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 2014,75(2),287-297","journal-title":"Ann Neurol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"371","DOI":"10.12688\/f1000research.10476.1","volume":"6","author":"Martin S.","year":"2017","unstructured":"Martin S.; Al Khleifat A.; Al-Chalabi A.; What causes amyotrophic lateral sclerosis? F1000 Res 2017,6,371","journal-title":"F1000 Res"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","volume":"13","author":"Al-Chalabi A.","year":"2017","unstructured":"Al-Chalabi A.; van den Berg L.H.; Veldink J.; Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 2017,13(2),96-104","journal-title":"Nat Rev Neurol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"2881.e11","DOI":"10.1016\/j.neurobiolaging.2014.07.003","volume":"35","author":"Liu Z.J.","year":"2014","unstructured":"Liu Z.J.; Li H.F.; Tan G.H.; Tao Q.Q.; Ni W.; Cheng X.W.; Xiong Z.Q.; Wu Z.Y.; Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system. Neurobiol Aging 2014,35(12),2881.e11-2881.e15","journal-title":"Neurobiol Aging"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"Neumann M.","year":"2006","unstructured":"Neumann M.; Sampathu D.M.; Kwong L.K.; Truax A.C.; Micsenyi M.C.; Chou T.T.; Bruce J.; Schuck T.; Grossman M.; Clark C.M.; McCluskey L.F.; Miller B.L.; Masliah E.; Mackenzie I.R.; Feldman H.; Feiden W.; Kretzschmar H.A.; Trojanowski J.Q.; Lee V.M.; Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006,314(5796),130-133","journal-title":"Science"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"Arai T.","year":"2006","unstructured":"Arai T.; Hasegawa M.; Akiyama H.; Ikeda K.; Nonaka T.; Mori H.; Mann D.; Tsuchiya K.; Yoshida M.; Hashizume Y.; Oda T.; TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclero-sis. Biochem Biophys Res Commun 2006,351(3),602-611","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","volume":"11","author":"Majounie E.","year":"2012","unstructured":"Majounie E.; Renton A.E.; Mok K.; Dopper E.G.; Waite A.; Rollinson S.; Chi&#xF2; A.; Restagno G.; Nicolaou N.; Simon-Sanchez J.; van Swieten J.C.; Abramzon Y.; Johnson J.O.; Sendtner M.; Pamphlett R.; Orrell R.W.; Mead S.; Sidle K.C.; Houlden H.; Rohrer J.D.; Morrison K.E.; Pall H.; Talbot K.; Ansorge O.; Hernandez D.G.; Arepalli S.; Sabatelli M.; Mora G.; Corbo M.; Giannini F.; Calvo A.; Englund E.; Borghero G.; Floris G.L.; Remes A.M.; Laaksovirta H.; McCluskey L.; Trojanowski J.Q.; Van Deerlin V.M.; Schel-lenberg G.D.; Nalls M.A.; Drory V.E.; Lu C.S.; Yeh T.H.; Ishiura H.; Takahashi Y.; Tsuji S.; Le Ber I.; Brice A.; Drepper C.; Wil-liams N.; Kirby J.; Shaw P.; Hardy J.; Tienari P.J.; Heutink P.; Morris H.R.; Pickering-Brown S.; Traynor B.J.; Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 2012,11(4),323-330","journal-title":"Lancet Neurol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3233\/JAD-131028","volume":"38","author":"Benussi L.","year":"2014","unstructured":"Benussi L.; Rossi G.; Glionna M.; Tonoli E.; Piccoli E.; Fostinelli S.; Paterlini A.; Flocco R.; Albani D.; Pantieri R.; Cereda C.; For-loni G.; Tagliavini F.; Binetti G.; Ghidoni R.; C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. J Alzheimers Dis 2014,38(4),799-808","journal-title":"J Alzheimers Dis"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11825-018-0185-3","volume":"30","author":"Volk A.E.","year":"2018","unstructured":"Volk A.E.; Weishaupt J.H.; Andersen P.M.; Ludolph A.C.; Kubisch C.; Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med Genetik 2018,30(2),252-258","journal-title":"Med Genetik"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/nn.4604","volume":"20","author":"Walker C.","year":"2017","unstructured":"Walker C.; Herranz-Martin S.; Karyka E.; Liao C.; Lewis K.; Elsayed W.; Lukashchuk V.; Chiang S.C.; Ray S.; Mulcahy P.J.; Jurga M.; Tsagakis I.; Iannitti T.; Chandran J.; Coldicott I.; De Vos K.J.; Hassan M.K.; Higginbottom A.; Shaw P.J.; Hautbergue G.M.; Az-zouz M.; El-Khamisy S.F.; C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci 2017,20(9),1225-1235","journal-title":"Nat Neurosci"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"Taylor J.P.","year":"2016","unstructured":"Taylor J.P.; Brown R.H.; Cleveland D.W.; Decoding ALS: from genes to mechanism. Nature 2016,539(7628),197-206","journal-title":"Nature"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4103\/ijp.IJP_823_19","volume":"51","author":"Batra G.","year":"2019","unstructured":"Batra G.; Jain M.; Singh R.S.; Sharma A.R.; Singh A.; Prakash A.; Medhi B.; Novel therapeutic targets for amyotrophic lateral sclerosis. Indian J Pharmacol 2019,51(6),418-425","journal-title":"Indian J Pharmacol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2013.03.019","volume":"330","author":"Garc&#xED;a M.L.","year":"2013","unstructured":"Garc&#xED;a M.L.; Fern&#xE1;ndez A.; Solas M.T.; Mitochondria, motor neurons and aging. J Neurol Sci 2013,330(1-2),18-26","journal-title":"J Neurol Sci"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2013.12.005","volume":"559","author":"Ono Y.","year":"2014","unstructured":"Ono Y.; Tanaka H.; Takata M.; Nagahara Y.; Noda Y.; Tsuruma K.; Shimazawa M.; Hozumi I.; Hara H.; SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett 2014,559,174-178","journal-title":"Neurosci Lett"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/ars.2009.2444","volume":"11","author":"Foran E.","year":"2009","unstructured":"Foran E.; Trotti D.; Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 2009,11(7),1587-1602","journal-title":"Antioxid Redox Signal"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","volume":"20","author":"Lin C.L.","year":"1998","unstructured":"Lin C.L.; Bristol L.A.; Jin L.; Dykes-Hoberg M.; Crawford T.; Clawson L.; Rothstein J.D.; Aberrant RNA processing in a neurodegen-erative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998,20(3),589-602","journal-title":"Neuron"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"Blokhuis A.M.","year":"2013","unstructured":"Blokhuis A.M.; Groen E.J.; Koppers M.; van den Berg L.H.; Pasterkamp R.J.; Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013,125(6),777-794","journal-title":"Acta Neuropathol"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/jcmm.13976","volume":"23","author":"Gagliardi D.","year":"2019","unstructured":"Gagliardi D.; Comi G.P.; Bresolin N.; Corti S.; MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis. J Cell Mol Med 2019,23(3),1647-1656","journal-title":"J Cell Mol Med"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"10105","DOI":"10.1038\/s41598-018-28366-1","volume":"8","author":"Rizzuti M.","year":"2018","unstructured":"Rizzuti M.; Filosa G.; Melzi V.; Calandriello L.; Dioni L.; Bollati V.; Bresolin N.; Comi G.P.; Barabino S.; Nizzardo M.; Corti S.; MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. Sci Rep 2018,8(1),10105","journal-title":"Sci Rep"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2017.01.034","volume":"1662","author":"Li L.H.","year":"2017","unstructured":"Li L.H.; Tu Q.Y.; Deng X.H.; Xia J.; Hou D.R.; Guo K.; Zi X.H.; Mutant presenilin2 promotes apoptosis through the p53\/miR-34a axis in neuronal cells. Brain Res 2017,1662,57-64","journal-title":"Brain Res"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"14221","DOI":"10.18632\/oncotarget.13991","volume":"8","author":"McCubrey J.A.","year":"2017","unstructured":"McCubrey J.A.; Fitzgerald T.L.; Yang L.V.; Lertpiriyapong K.; Steelman L.S.; Abrams S.L.; Montalto G.; Cervello M.; Neri L.M.; Cocco L.; Martelli A.M.; Laidler P.; Duli\u0144ska-Litewka, J.; Rakus, D.; Gizak, A.; Nicoletti, F.; Falzone, L.; Candido, S.; Libra, M. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells. Oncotarget 2017,8(8),14221-14250","journal-title":"Oncotarget"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fnins.2017.00731","volume":"11","author":"Waller R.","year":"2018","unstructured":"Waller R.; Wyles M.; Heath P.R.; Kazoka M.; Wollff H.; Shaw P.J.; Kirby J.; Small R.N.A.; Sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front Neurosci 2018,11,731","journal-title":"Front Neurosci"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.biopha.2017.03.011","volume":"89","author":"Wang N.","year":"2017","unstructured":"Wang N.; Zhang L.; Lu Y.; Zhang M.; Zhang Z.; Wang K.; Lv J.; Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2\/ARE signaling pathway. Biomed Pharmacother 2017,89,1187-1195","journal-title":"Biomed Pharmacother"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1073\/pnas.1312245111","volume":"111","author":"Grad L.I.","year":"2014","unstructured":"Grad L.I.; Yerbury J.J.; Turner B.J.; Guest W.C.; Pokrishevsky E.; O\u2019Neill M.A.; Yanai A.; Silverman J.M.; Zeineddine R.; Corcoran L.; Kumita J.R.; Luheshi L.M.; Yousefi M.; Coleman B.M.; Hill A.F.; Plotkin S.S.; Mackenzie I.R.; Cashman N.R.; Intercellular propa-gated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2014,111(9),3620-3625","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"Compston A.","year":"2008","unstructured":"Compston A.; Coles A.; Multiple sclerosis. Lancet 2008,372(9648),1502-1517","journal-title":"Lancet"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0733-8619(05)70257-7","volume":"14","author":"Weinshenker B.G.","year":"1996","unstructured":"Weinshenker B.G.; Epidemiology of multiple sclerosis. Neurol Clin 1996,14(2),291-308","journal-title":"Neurol Clin"},{"key":"ref=217","author":"Brust C.M.","year":"2012","unstructured":"Brust C.M.;  Current diagnosis  2012","journal-title":"Current diagnosis"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"Koch-Henriksen N.","year":"2010","unstructured":"Koch-Henriksen N.; S&#xF8;rensen P.S.; The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010,9(5),520-532","journal-title":"Lancet Neurol"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s100720070055","volume":"21","author":"Kurtzke J.F.","year":"2000","unstructured":"Kurtzke J.F.; Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis Neurol Sci 2000,21(6),383-403","journal-title":"Lectio Doctoralis Neurol Sci"},{"key":"ref=220","first-page":"1","volume":"19","author":"Ghasemi N.","year":"2017","unstructured":"Ghasemi N.; Razavi S.; Nikzad E.; Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J 2017,19(1),1-10","journal-title":"Cell J"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1756285611403646","volume":"4","author":"de Sa J.C.","year":"2011","unstructured":"de Sa J.C.; Airas L.; Bartholome E.; Grigoriadis N.; Mattle H.; Oreja-Guevara C.; O\u2019Riordan J.; Sellebjerg F.; Stankoff B.; Vass K.; Walczak A.; Wiendl H.; Kieseier B.C.; Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord 2011,4(3),139-168","journal-title":"Ther Adv Neurol Disord"},{"key":"ref=222","first-page":"116","author":"Holland B.E.","year":"2014","unstructured":"Holland B.E.;  Factors affecting quality of life in persons with multiple sclerosis The University of Texas at Arlington 2014,116","journal-title":"Factors affecting quality of life in persons with multiple sclerosis The University of Texas at Arlington"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3892\/etm.2017.4410","volume":"13","author":"Huang W.J.","year":"2017","unstructured":"Huang W.J.; Chen W.W.; Zhang X.; Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med 2017,13(6),3163-3166","journal-title":"Exp Ther Med"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","volume":"255","author":"Weiner H.L.","year":"2008","unstructured":"Weiner H.L.; A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008,255(Suppl. 1),3-11","journal-title":"J Neurol"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","volume":"221","author":"Gandhi R.","year":"2010","unstructured":"Gandhi R.; Laroni A.; Weiner H.L.; Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 2010,221(1-2),7-14","journal-title":"J Neuroimmunol"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.0b013e3181c97c8f","volume":"74","author":"Kasper L.H.","year":"2010","unstructured":"Kasper L.H.; Shoemaker J.; Multiple sclerosis immunology: The healthy immune system vs. the MS immune system. Neurology 2010,74(Suppl. 1),S2-S8","journal-title":"Neurology"},{"key":"ref=227","first-page":"250","volume":"17","author":"Kouchaki E.","year":"2014","unstructured":"Kouchaki E.; Salehi M.; Reza Sharif M.; Nikoueinejad H.; Akbari H.; Numerical status of CD4+CD25+FoxP3+ and CD8+CD28- regulatory T cells in multiple sclerosis. Iran J Basic Med Sci 2014,17(4),250-255","journal-title":"Iran J Basic Med Sci"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/glia.21266","volume":"60","author":"Olah M.","year":"2012","unstructured":"Olah M.; Amor S.; Brouwer N.; Vinet J.; Eggen B.; Biber K.; Boddeke H.W.; Identification of a microglia phenotype supportive of remyelination. Glia 2012,60(2),306-321","journal-title":"Glia"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"11421","DOI":"10.1523\/JNEUROSCI.2251-04.2004","volume":"24","author":"Roumier A.","year":"2004","unstructured":"Roumier A.; B&#xE9;chade C.; Poncer J.C.; Smalla K.H.; Tomasello E.; Vivier E.; Gundelfinger E.D.; Triller A.; Bessis A.; Impaired synap-tic function in the microglial KARAP\/DAP12-deficient mouse. J Neurosci 2004,24(50),11421-11428","journal-title":"J Neurosci"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1523\/JNEUROSCI.4363-08.2009","volume":"29","author":"Wake H.","year":"2009","unstructured":"Wake H.; Moorhouse A.J.; Jinno S.; Kohsaka S.; Nabekura J.; Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 2009,29(13),3974-3980","journal-title":"J Neurosci"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fneur.2017.00422","volume":"8","author":"Blonda M.","year":"2017","unstructured":"Blonda M.; Amoruso A.; Grasso R.; Di Francescantonio V.; Avolio C.; Multiple sclerosis treatments affect monocyte-derived mi-crovesicle production. Front Neurol 2017,8,422","journal-title":"Front Neurol"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-13-0265","volume":"73","author":"Roberts C.T.","year":"2013","unstructured":"Roberts C.T.; Kurre P.; Vesicle trafficking and RNA transfer add complexity and connectivity to cell-cell communication. Cancer Res 2013,73(11),3200-3205","journal-title":"Cancer Res"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"Vickers K.C.","year":"2011","unstructured":"Vickers K.C.; Palmisano B.T.; Shoucri B.M.; Shamburek R.D.; Remaley A.T.; MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011,13(4),423-433","journal-title":"Nat Cell Biol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MOL.0b013e328350a425","volume":"23","author":"Vickers K.C.","year":"2012","unstructured":"Vickers K.C.; Remaley A.T.; Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012,23(2),91-97","journal-title":"Curr Opin Lipidol"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"e30679","DOI":"10.1371\/journal.pone.0030679","volume":"7","author":"Gallo A.","year":"2012","unstructured":"Gallo A.; Tandon M.; Alevizos I.; Illei G.G.; The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012,7(3),e30679","journal-title":"PLoS One"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"E1433","DOI":"10.1073\/pnas.1418401112","volume":"112","author":"Kanada M.","year":"2015","unstructured":"Kanada M.; Bachmann M.H.; Hardy J.W.; Frimannson D.O.; Bronsart L.; Wang A.; Sylvester M.D.; Schmidt T.L.; Kaspar R.L.; Butte M.J.; Matin A.C.; Contag C.H.; Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci USA 2015,112(12),E1433-E1442","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fncel.2014.00100","volume":"8","author":"S&#xE1;enz-Cuesta M.","year":"2014","unstructured":"S&#xE1;enz-Cuesta M.; Osorio-Querejeta I.; Otaegui D.; Extracellular vesicles in multiple sclerosis: What are they telling us? Front Cell Neurosci 2014,8,100","journal-title":"Front Cell Neurosci"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1517\/14728222.2013.838219","volume":"17","author":"Zare-Shahabadi A.","year":"2013","unstructured":"Zare-Shahabadi A.; Renaudineau Y.; Rezaei N.; MicroRNAs and multiple sclerosis: from physiopathology toward therapy. Expert Opin Ther Targets 2013,17(12),1497-1507","journal-title":"Expert Opin Ther Targets"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fimmu.2016.00129","volume":"7","author":"Jagot F.","year":"2016","unstructured":"Jagot F.; Davoust N.; Is It worth Considering Circulating microRNAs in Multiple Sclerosis? Front Immunol 2016,7,129","journal-title":"Front Immunol"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.1190927","volume":"330","author":"Emery B.","year":"2010","unstructured":"Emery B.; Regulation of oligodendrocyte differentiation and myelination. Science 2010,330(6005),779-782","journal-title":"Science"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2008.12.027","volume":"136","author":"Xiao C.","year":"2009","unstructured":"Xiao C.; Rajewsky K.; MicroRNA control in the immune system: basic principles. Cell 2009,136(1),26-36","journal-title":"Cell"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1212\/NXI.0000000000000491","volume":"5","author":"Regev K.","year":"2018","unstructured":"Regev K.; Healy B.C.; Paul A.; Diaz-Cruz C.; Mazzola M.A.; Raheja R.; Glanz B.I.; Kivis&#xE4;kk P.; Chitnis T.; Jagodic M.; Piehl F.; Olsson T.; Khademi M.; Hauser S.; Oksenberg J.; Khoury S.J.; Weiner H.L.; Gandhi R.; Identification of MS-specific serum miRNAs in an international multicenter study. Neurol Neuroimmunol Neuroinflamm 2018,5(5),e491","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nn.2294","volume":"12","author":"Cheng L.C.","year":"2009","unstructured":"Cheng L.C.; Pastrana E.; Tavazoie M.; Doetsch F.; miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009,12(4),399-408","journal-title":"Nat Neurosci"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/ni.1798","volume":"10","author":"Du C.","year":"2009","unstructured":"Du C.; Liu C.; Kang J.; Zhao G.; Ye Z.; Huang S.; Li Z.; Wu Z.; Pei G.; MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009,10(12),1252-1259","journal-title":"Nat Immunol"},{"key":"ref=245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/19325037.2008.10599033","volume":"39","author":"Eve D.J.","year":"2008","unstructured":"Eve D.J.; Marty P.J.; McDermott R.J.; Klasko S.K.; Sanberg P.; Resource for stem cell research. Am J Health Educ 2008,39(3),167-179","journal-title":"Am J Health Educ"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/cr.2009.56","volume":"19","author":"Ma D.K.","year":"2009","unstructured":"Ma D.K.; Bonaguidi M.A.; Ming G.L.; Song H.; Adult neural stem cells in the mammalian central nervous system. Cell Res 2009,19(6),672-682","journal-title":"Cell Res"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"9864","DOI":"10.1073\/pnas.142298299","volume":"99","author":"Drukker M.","year":"2002","unstructured":"Drukker M.; Katz G.; Urbach A.; Schuldiner M.; Markel G.; Itskovitz-Eldor J.; Reubinoff B.; Mandelboim O.; Benvenisty N.; Charac-terization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002,99(15),9864-9869","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","volume":"24","author":"Biehl J.K.","year":"2009","unstructured":"Biehl J.K.; Russell B.; Introduction to stem cell therapy. J Cardiovasc Nurs 2009,24(2),98-103","journal-title":"J Cardiovasc Nurs"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cell.2008.01.015","volume":"132","author":"Jaenisch R.","year":"2008","unstructured":"Jaenisch R.; Young R.; Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008,132(4),567-582","journal-title":"Cell"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.07.020","volume":"134","author":"Marson A.","year":"2008","unstructured":"Marson A.; Levine S.S.; Cole M.F.; Frampton G.M.; Brambrink T.; Johnstone S.; Guenther M.G.; Johnston W.K.; Wernig M.; New-man J.; Calabrese J.M.; Dennis L.M.; Volkert T.L.; Gupta S.; Love J.; Hannett N.; Sharp P.A.; Bartel D.P.; Jaenisch R.; Young R.A.; Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008,134(3),521-533","journal-title":"Cell"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2106\/JBJS.D.02104","volume":"87","author":"Alhadlaq A.","year":"2005","unstructured":"Alhadlaq A.; Mao J.J.; Tissue-engineered osteochondral constructs in the shape of an articular condyle. J Bone Joint Surg Am 2005,87(5),936-944","journal-title":"J Bone Joint Surg Am"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1056\/NEJM198704023161402","volume":"316","author":"Madrazo I.","year":"1987","unstructured":"Madrazo I.; Drucker-Col&#xED;n R.; D&#xED;az V.; Mart&#xED;nez-Mata J.; Torres C.; Becerril J.J.; Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson\u2019s disease. N Engl J Med 1987,316(14),831-834","journal-title":"N Engl J Med"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","volume":"21","author":"Barker R.A.","year":"2017","unstructured":"Barker R.A.; Parmar M.; Studer L.; Takahashi J.; Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson\u2019s Disease: Dawn of a New Era. Cell Stem Cell 2017,21(5),569-573","journal-title":"Cell Stem Cell"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.pbr.2016.11.011","volume":"230","author":"Kirkeby A.","year":"2017","unstructured":"Kirkeby A.; Parmar M.; Barker R.A.; Strategies for bringing stem\ncell-derived dopamine neurons to the clinic: A European approach\n(STEM-PD). Prog Brain Res 2017,230,165-190","journal-title":"Prog Brain Res"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.stem.2013.05.018","volume":"12","author":"Yu D.X.","year":"2013","unstructured":"Yu D.X.; Marchetto M.C.; Gage F.H.; Therapeutic translation of iPSCs for treating neurological disease. Cell Stem Cell 2013,12(6),678-688","journal-title":"Cell Stem Cell"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/JAD-160406","volume":"54","author":"Kang J.M.","year":"2016","unstructured":"Kang J.M.; Yeon B.K.; Cho S.J.; Suh Y.H.; Stem Cell Therapy for Alzheimer\u2019s Disease: A Review of Recent Clinical Trials. J Alzheimers Dis 2016,54(3),879-889","journal-title":"J Alzheimers Dis"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2008.12.001","volume":"450","author":"Xuan A.G.","year":"2009","unstructured":"Xuan A.G.; Luo M.; Ji W.D.; Long D.H.; Effects of engrafted neural stem cells in Alzheimer\u2019s disease rats. Neurosci Lett 2009,450(2),167-171","journal-title":"Neurosci Lett"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMp1613723","volume":"376","author":"Marks P.W.","year":"2017","unstructured":"Marks P.W.; Witten C.M.; Califf R.M.; Clarifying Stem-Cell Therapy\u2019s Benefits and Risks. N Engl J Med 2017,376(11),1007-1009","journal-title":"N Engl J Med"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc3798","volume":"14","author":"Stuckey D.W.","year":"2014","unstructured":"Stuckey D.W.; Shah K.; Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer 2014,14(10),683-691","journal-title":"Nat Rev Cancer"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1517\/14712598.8.3.255","volume":"8","author":"Granero-Molto F.","year":"2008","unstructured":"Granero-Molto F.; Weis J.A.; Longobardi L.; Spagnoli A.; Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 2008,8(3),255-268","journal-title":"Expert Opin Biol Ther"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"Wei X.","year":"2013","unstructured":"Wei X.; Yang X.; Han Z.P.; Qu F.F.; Shao L.; Shi Y.F.; Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 2013,34(6),747-754","journal-title":"Acta Pharmacol Sin"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00018-009-0202-4","volume":"67","author":"Siniscalco D.","year":"2010","unstructured":"Siniscalco D.; Giordano C.; Galderisi U.; Luongo L.; Alessio N.; Di Bernardo G.; de Novellis V.; Rossi F.; Maione S.; Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci 2010,67(4),655-669","journal-title":"Cell Mol Life Sci"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1007\/s00018-013-1290-8","volume":"70","author":"Teixeira F.G.","year":"2013","unstructured":"Teixeira F.G.; Carvalho M.M.; Sousa N.; Salgado A.J.; Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci 2013,70(20),3871-3882","journal-title":"Cell Mol Life Sci"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4103\/1673-5374.158352","volume":"10","author":"Castorina A.","year":"2015","unstructured":"Castorina A.; Szychlinska M.A.; Marzagalli R.; Musumeci G.; Mesenchymal stem cells-based therapy as a potential treatment in neuro-degenerative disorders: is the escape from senescence an answer? Neural Regen Res 2015,10(6),850-858","journal-title":"Neural Regen Res"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1212\/WNL.59.4.514","volume":"59","author":"Li Y.","year":"2002","unstructured":"Li Y.; Chen J.; Chen X.G.; Wang L.; Gautam S.C.; Xu Y.X.; Katakowski M.; Zhang L.J.; Lu M.; Janakiraman N.; Chopp M.; Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002,59(4),514-523","journal-title":"Neurology"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00001199-200307000-00006","volume":"18","author":"Lu D.","year":"2003","unstructured":"Lu D.; Mahmood A.; Chopp M.; Biologic transplantation and neurotrophin-induced neuroplasticity after traumatic brain injury. J Head Trauma Rehabil 2003,18(4),357-376","journal-title":"J Head Trauma Rehabil"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/089771504772695922","volume":"21","author":"Mahmood A.","year":"2004","unstructured":"Mahmood A.; Lu D.; Chopp M.; Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 2004,21(1),33-39","journal-title":"J Neurotrauma"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/jnr.10334","volume":"69","author":"Chen X.","year":"2002","unstructured":"Chen X.; Katakowski M.; Li Y.; Lu D.; Wang L.; Zhang L.; Chen J.; Xu Y.; Gautam S.; Mahmood A.; Chopp M.; Human bone mar-row stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 2002,69(5),687-691","journal-title":"J Neurosci Res"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/stem.1129","volume":"30","author":"Xin H.","year":"2012","unstructured":"Xin H.; Li Y.; Buller B.; Katakowski M.; Zhang Y.; Wang X.; Shang X.; Zhang Z.G.; Chopp M.; Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 2012,30(7),1556-1564","journal-title":"Stem Cells"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","volume":"33","author":"Xin H.","year":"2013","unstructured":"Xin H.; Li Y.; Cui Y.; Yang J.J.; Zhang Z.G.; Chopp M.; Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013,33(11),1711-1715","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/sctm.18-0226","volume":"8","author":"Baek G.","year":"2019","unstructured":"Baek G.; Choi H.; Kim Y.; Lee H.C.; Choi C.; Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform. Stem Cells Transl Med 2019,8(9),880-886","journal-title":"Stem Cells Transl Med"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.2147\/IJN.S200036","volume":"14","author":"Vakhshiteh F.","year":"2019","unstructured":"Vakhshiteh F.; Atyabi F.; Ostad S.N.; Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomedicine 2019,14,2847-2859","journal-title":"Int J Nanomedicine"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1158\/0008-5472.CAN-11-0241","volume":"71","author":"Grange C.","year":"2011","unstructured":"Grange C.; Tapparo M.; Collino F.; Vitillo L.; Damasco C.; Deregibus M.C.; Tetta C.; Bussolati B.; Camussi G.; Microvesicles re-leased from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 2011,71(15),5346-5356","journal-title":"Cancer Res"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"346","DOI":"10.18632\/oncotarget.868","volume":"4","author":"Lee H.K.","year":"2013","unstructured":"Lee H.K.; Finniss S.; Cazacu S.; Bucris E.; Ziv-Av A.; Xiang C.; Bobbitt K.; Rempel S.A.; Hasselbach L.; Mikkelsen T.; Slavin S.; Brodie C.; Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migra-tion and self-renewal. Oncotarget 2013,4(2),346-361","journal-title":"Oncotarget"},{"key":"ref=275","year":"2020","unstructured":"The Safety and the Efficacy Evaluation of Allogenic Adipose\nMSC-Exos in Patients With Alzheimer's Disease. In: ClinicalTrials\ngov; 2020","journal-title":"ClinicalTrials\ngov;"},{"key":"ref=276","year":"2021","unstructured":"Therapeutic Potential of Stem Cell Conditioned Medium on Chronic\nUlcer Wounds. In: ClinicalTrialsgov; 2021","journal-title":"ClinicalTrialsgov;"},{"key":"ref=277","year":"2021","unstructured":"microRNAs Role in Pre-eclampsia Diagnosis. In: ClinicalTrials\ngov 2021","journal-title":"ClinicalTrials\ngov"},{"key":"ref=278","year":"2021","unstructured":"Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion\nSyndrome After Surgical Repaire of Acute Type A Aortic Dissection.\nIn: ClinicalTrialsgov 2021","journal-title":"ClinicalTrialsgov"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nn2010","volume":"10","author":"Klein M.E.","year":"2007","unstructured":"Klein M.E.; Lioy D.T.; Ma L.; Impey S.; Mandel G.; Goodman R.H.; Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 2007,10(12),1513-1514","journal-title":"Nat Neurosci"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1093\/hmg\/ddr330","volume":"20","author":"Smith P.Y.","year":"2011","unstructured":"Smith P.Y.; Delay C.; Girard J.; Papon M.A.; Planel E.; Sergeant N.; Bu&#xE9;e L.; H&#xE9;bert S.S.; MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 2011,20(20),4016-4024","journal-title":"Hum Mol Genet"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"114065","DOI":"10.18632\/oncotarget.23119","volume":"8","author":"An F.","year":"2017","unstructured":"An F.; Gong G.; Wang Y.; Bian M.; Yu L.; Wei C.; MiR-124 acts as a target for Alzheimer\u2019s disease by regulating BACE1. Oncotarget 2017,8(69),114065-114071","journal-title":"Oncotarget"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"H&#xE9;bert S.S.","year":"2008","unstructured":"H&#xE9;bert S.S.; Horr&#xE9; K.; Nicola&#xEF; L.; Papadopoulou A.S.; Mandemakers W.; Silahtaroglu A.N.; Kauppinen S.; Delacourte A.; De Stroop-er B.; Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci USA 2008,105(17),6415-6420","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2020.1734842","author":"Madadi S.","year":"2020","unstructured":"Madadi S.; Saidijam M.; Yavari B.; Soleimani M.; Downregulation of serum miR-106b: a potential biomarker for Alzheimer disease. Arch Physiol Biochem 2020,1-5","journal-title":"Arch Physiol Biochem"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","volume":"1583","author":"Liu C.G.","year":"2014","unstructured":"Liu C.G.; Wang J.L.; Li L.; Xue L.X.; Zhang Y.Q.; Wang P.C.; MicroRNA-135a and -200b, potential Biomarkers for Alzheimers disease, regulate &#x3B2; secretase and amyloid precursor protein. Brain Res 2014,1583,55-64","journal-title":"Brain Res"},{"key":"ref=285","first-page":"87","volume":"31","author":"Yang T.T.","year":"2018","unstructured":"Yang T.T.; Liu C.G.; Gao S.C.; Zhang Y.; Wang P.C.; The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer\u2019s Disease Biomarkers. Biomed Environ Sci 2018,31(2),87-96","journal-title":"Biomed Environ Sci"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/WNR.0b013e32835542b0","volume":"23","author":"Lukiw W.J.","year":"2012","unstructured":"Lukiw W.J.; Alexandrov P.N.; Zhao Y.; Hill J.M.; Bhattacharjee S.; Spreading of Alzheimer\u2019s disease inflammatory signaling through soluble micro-RNA. Neuroreport 2012,23(10),621-626","journal-title":"Neuroreport"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13024-018-0285-1","volume":"13","author":"Sierksma A.","year":"2018","unstructured":"Sierksma A.; Lu A.; Salta E.; Vanden Eynden E.; Callaerts-Vegh Z.; D\u2019Hooge R.; Blum D.; Bu&#xE9;e L.; Fiers M.; De Strooper B.; Dereg-ulation of neuronal miRNAs induced by amyloid-&#x3B2; or TAU pathology. Mol Neurodegener 2018,13(1),54","journal-title":"Mol Neurodegener"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1242\/dmm.031708","author":"Li T.R.","year":"2018","unstructured":"Li T.R.; Jia Y.J.; Ma C.; Qiu W.Y.; Wang Q.; Shao X.Q.; Lv R.J.; The role of the microRNA-146a\/complement factor H\/interleukin-1&#x3B2;-mediated inflammatory loop circuit in the perpetuate inflammation of chronic temporal lobe epilepsy. Dis Model Mech 2018,11","journal-title":"Dis Model Mech"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","volume":"287","author":"Long J.M.","year":"2012","unstructured":"Long J.M.; Ray B.; Lahiri D.K.; MicroRNA-153 physiologically inhibits expression of amyloid-&#x3B2; precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J Biol Chem 2012,287(37),31298-31310","journal-title":"J Biol Chem"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.3892\/ol.2019.10862","volume":"18","author":"Wang H.","year":"2019","unstructured":"Wang H.; Li X.; Li T.; Wang L.; Wu X.; Liu J.; Xu Y.; Wei W.; Multiple roles of microRNA-146a in immune responses and hepatocel-lular carcinoma. Oncol Lett 2019,18(5),5033-5042","journal-title":"Oncol Lett"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fneur.2020.00288","volume":"11","author":"Kou X.","year":"2020","unstructured":"Kou X.; Chen D.; Chen N.; The Regulation of microRNAs in Alzheimer\u2019s Disease. Front Neurol 2020,11,288","journal-title":"Front Neurol"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1038\/mtna.2015.33","volume":"4","author":"Parsi S.","year":"2015","unstructured":"Parsi S.; Smith P.Y.; Goupil C.; Dorval V.; H&#xE9;bert S.S.; Preclinical Evaluation of miR-15\/107 Family Members as Multifactorial Drug Targets for Alzheimer\u2019s Disease. Mol Ther Nucleic Acids 2015,4,e256","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"H&#xE9;bert S.S.","year":"2009","unstructured":"H&#xE9;bert S.S.; Horr&#xE9; K.; Nicola&#xEF; L.; Bergmans B.; Papadopoulou A.S.; Delacourte A.; De Strooper B.; MicroRNA regulation of Alz-heimer\u2019s Amyloid precursor protein expression. Neurobiol Dis 2009,33(3),422-428","journal-title":"Neurobiol Dis"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1750-1326-6-70","volume":"6","author":"Delay C.","year":"2011","unstructured":"Delay C.; Calon F.; Mathews P.; H&#xE9;bert S.S.; Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener 2011,6,70","journal-title":"Mol Neurodegener"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"Tan L.","year":"2014","unstructured":"Tan L.; Yu J.T.; Liu Q.Y.; Tan M.S.; Zhang W.; Hu N.; Wang Y.L.; Sun L.; Jiang T.; Tan L.; Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci 2014,336(1-2),52-56","journal-title":"J Neurol Sci"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"14820","DOI":"10.1523\/JNEUROSCI.3883-11.2011","volume":"31","author":"Geekiyanage H.","year":"2011","unstructured":"Geekiyanage H.; Chan C.; MicroRNA-137\/181c regulates serine palmitoyltransferase and in turn amyloid &#x3B2; novel targets in sporadic Alzheimer\u2019s disease. J Neurosci 2011,31(41),14820-14830","journal-title":"J Neurosci"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1074\/jbc.M807530200","volume":"284","author":"Boissonneault V.","year":"2009","unstructured":"Boissonneault V.; Plante I.; Rivest S.; Provost P.; MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid pre-cursor protein-converting enzyme 1. J Biol Chem 2009,284(4),1971-1981","journal-title":"J Biol Chem"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"O\u2019Brien R.J.","year":"2011","unstructured":"O\u2019Brien R.J.; Wong P.C.; Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 2011,34,185-204","journal-title":"Annu Rev Neurosci"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fgene.2019.00153","volume":"10","author":"Wang M.","year":"2019","unstructured":"Wang M.; Qin L.; Tang B.; MicroRNAs in Alzheimer\u2019s Disease. Front Genet 2019,10,153","journal-title":"Front Genet"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.biopsych.2017.07.023","volume":"83","author":"Wang X.","year":"2018","unstructured":"Wang X.; Liu D.; Huang H.Z.; Wang Z.H.; Hou T.Y.; Yang X.; Pang P.; Wei N.; Zhou Y.F.; Dupras M.J.; Calon F.; Wang Y.T.; Man H.Y.; Chen J.G.; Wang J.Z.; H&#xE9;bert S.S.; Lu Y.; Zhu L.Q.; A Novel MicroRNA-124\/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer\u2019s Disease. Biol Psychiatry 2018,83(5),395-405","journal-title":"Biol Psychiatry"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1460-9568.2005.03978.x","volume":"21","author":"Smirnova L.","year":"2005","unstructured":"Smirnova L.; Gr&#xE4;fe A.; Seiler A.; Schumacher S.; Nitsch R.; Wulczyn F.G.; Regulation of miRNA expression during neural cell specifi-cation. Eur J Neurosci 2005,21(6),1469-1477","journal-title":"Eur J Neurosci"},{"key":"ref=302","author":"Cao J.","year":"2020","unstructured":"Cao J.; Huang M.; Guo L.; Zhu L.; Hou J.; Zhang L.; Pero A.; Ng S.; El Gaamouch F.; Elder G.; Sano M.; Goate A.; Tcw J.; Haroutunian V.; Zhang B.; Cai D.; MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer\u2019s dis-ease pathogenesis. Mol Psychiatry 2020","journal-title":"Mol Psychiatry"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1101\/gad.1975411","volume":"25","author":"Kole A.J.","year":"2011","unstructured":"Kole A.J.; Swahari V.; Hammond S.M.; Deshmukh M.; miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev 2011,25(2),125-130","journal-title":"Genes Dev"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","volume":"1646","author":"Sarkar S.","year":"2016","unstructured":"Sarkar S.; Jun S.; Rellick S.; Quintana D.D.; Cavendish J.Z.; Simpkins J.W.; Expression of microRNA-34a in Alzheimer\u2019s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 2016,1646,139-151","journal-title":"Brain Res"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"e0196929","DOI":"10.1371\/journal.pone.0196929","volume":"13","author":"Higaki S.","year":"2018","unstructured":"Higaki S.; Muramatsu M.; Matsuda A.; Matsumoto K.; Satoh J.I.; Michikawa M.; Niida S.; Defensive effect of microRNA-200b\/c against amyloid-beta peptide-induced toxicity in Alzheimer\u2019s disease models. PLoS One 2018,13(5),e0196929","journal-title":"PLoS One"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"109409","DOI":"10.1016\/j.biopha.2019.109409","volume":"119","author":"Fu J.","year":"2019","unstructured":"Fu J.; Peng L.; Tao T.; Chen Y.; Li Z.; Li J.; Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomed Pharmacother 2019,119,109409","journal-title":"Biomed Pharmacother"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","volume":"74","author":"Wang Z.H.","year":"2015","unstructured":"Wang Z.H.; Zhang J.L.; Duan Y.L.; Zhang Q.S.; Li G.F.; Zheng D.L.; MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting &#x3B1;-synuclein expression in MPTP-induced Parkinson\u2019s disease mouse. Biomed Pharmacother 2015,74,252-256","journal-title":"Biomed Pharmacother"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fnmol.2016.00128","volume":"9","author":"Recasens A.","year":"2016","unstructured":"Recasens A.; Perier C.; Sue C.M.; Role of microRNAs in the Regulation of &#x3B1;-Synuclein Expression: A Systematic Review. Front Mol Neurosci 2016,9,128","journal-title":"Front Mol Neurosci"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"1743183","DOI":"10.1155\/2019\/1743183","volume":"2019","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Wang Z.; MicroRNAs: Game Changers in the Regulation of &#x3B1;-Synuclein in Parkinson\u2019s Disease. Parkinsons Dis 2019,2019,1743183","journal-title":"Parkinsons Dis"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","volume":"21","author":"Dong H.","year":"2016","unstructured":"Dong H.; Wang C.; Lu S.; Yu C.; Huang L.; Feng W.; Xu H.; Chen X.; Zen K.; Yan Q.; Liu W.; Zhang C.; Zhang C.Y.; A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson\u2019s disease. Biomarkers 2016,21(2),129-137","journal-title":"Biomarkers"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.parkreldis.2016.09.028","volume":"33","author":"Tatura R.","year":"2016","unstructured":"Tatura R.; Kraus T.; Giese A.; Arzberger T.; Buchholz M.; H&#xF6;glinger G.; M&#xFC;ller U.; Parkinson\u2019s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat Disord 2016,33,115-121","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbadis.2014.11.019","volume":"1852","author":"Prajapati P.","year":"2015","unstructured":"Prajapati P.; Sripada L.; Singh K.; Bhatelia K.; Singh R.; Singh R.; TNF-&#x3B1; regulates miRNA targeting mitochondrial complex-I and in-duces cell death in dopaminergic cells. Biochim Biophys Acta 2015,1852(3),451-461","journal-title":"Biochim Biophys Acta"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1073\/pnas.0906277106","volume":"106","author":"Junn E.","year":"2009","unstructured":"Junn E.; Lee K.W.; Jeong B.S.; Chan T.W.; Im J.Y.; Mouradian M.M.; Repression of alpha-synuclein expression and toxicity by mi-croRNA-7. Proc Natl Acad Sci USA 2009,106(31),13052-13057","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Zhou Y.","year":"2016","unstructured":"Zhou Y.; Lu M.; Du R.H.; Qiao C.; Jiang C.Y.; Zhang K.Z.; Ding J.H.; Hu G.; MicroRNA-7 targets Nod-like receptor protein 3 in-flammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener 2016,11,28","journal-title":"Mol Neurodegener"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.freeradbiomed.2015.09.010","volume":"89","author":"Kabaria S.","year":"2015","unstructured":"Kabaria S.; Choi D.C.; Chaudhuri A.D.; Jain M.R.; Li H.; Junn E.; MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression. Free Radic Biol Med 2015,89,548-556","journal-title":"Free Radic Biol Med"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.M115.691352","volume":"291","author":"Chaudhuri A.D.","year":"2016","unstructured":"Chaudhuri A.D.; Choi D.C.; Kabaria S.; Tran A.; Junn E.; MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting VDAC1 expression. J Biol Chem 2016,291(12),6483-6493","journal-title":"J Biol Chem"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"Doxakis E.","year":"2010","unstructured":"Doxakis E.; Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 2010,285(17),12726-12734","journal-title":"J Biol Chem"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","volume":"110","author":"Decressac M.","year":"2013","unstructured":"Decressac M.; Mattsson B.; Weikop P.; Lundblad M.; Jakobsson J.; Bj&#xF6;rklund A.; TFEB-mediated autophagy rescues midbrain dopa-mine neurons from &#x3B1;-synuclein toxicity. Proc Natl Acad Sci USA 2013,110(19),E1817-E1826","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.neurobiolaging.2013.09.027","volume":"35","author":"Xiong R.","year":"2014","unstructured":"Xiong R.; Wang Z.; Zhao Z.; Li H.; Chen W.; Zhang B.; Wang L.; Wu L.; Li W.; Ding J.; Chen S.; MicroRNA-494 reduces DJ-1 ex-pression and exacerbates neurodegeneration. Neurobiol Aging 2014,35(3),705-714","journal-title":"Neurobiol Aging"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/hmg\/dds470","volume":"22","author":"Cho H.J.","year":"2013","unstructured":"Cho H.J.; Liu G.; Jin S.M.; Parisiadou L.; Xie C.; Yu J.; Sun L.; Ma B.; Ding J.; Vancraenenbroeck R.; Lobbestael E.; Baekelandt V.; Taymans J.M.; He P.; Troncoso J.C.; Shen Y.; Cai H.; MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leu-cine-rich repeat kinase 2 protein. Hum Mol Genet 2013,22(3),608-620","journal-title":"Hum Mol Genet"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/jhg.2014.26","volume":"59","author":"Cardo L.F.","year":"2014","unstructured":"Cardo L.F.; Coto E.; Ribacoba R.; Mata I.F.; Moris G.; Men&#xE9;ndez M.; Alvarez V.; The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson\u2019s disease. J Hum Genet 2014,59(6),346-348","journal-title":"J Hum Genet"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/WNR.0b013e32835fb6b0","volume":"24","author":"Zhao Y.","year":"2013","unstructured":"Zhao Y.; Bhattacharjee S.; Jones B.M.; Dua P.; Alexandrov P.N.; Hill J.M.; Lukiw W.J.; Regulation of TREM2 expression by an NF-&#x43A;B-sensitive miRNA-34a. Neuroreport 2013,24(6),318-323","journal-title":"Neuroreport"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnagi.2016.00140","volume":"8","author":"Zhao Y.","year":"2016","unstructured":"Zhao Y.; Jaber V.; Lukiw W.J.; Over-Expressed Pathogenic miRNAs in Alzheimer\u2019s Disease (AD) and Prion Disease (PrD) Drive Defi-cits in TREM2-Mediated A&#x3B2;42 Peptide Clearance. Front Aging Neurosci 2016,8,140","journal-title":"Front Aging Neurosci"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1042\/BCJ20190872","volume":"477","author":"Thackray A.M.","year":"2020","unstructured":"Thackray A.M.; Lam B.; Shahira B.; Ab Razak, A.; Yeo, G.; Bujdoso, R. Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease. Biochem J 2020,477(4),833-852","journal-title":"Biochem J"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/carcin\/bgv152","volume":"36","author":"Tai M.C.","year":"2015","unstructured":"Tai M.C.; Kajino T.; Nakatochi M.; Arima C.; Shimada Y.; Suzuki M.; Miyoshi H.; Yatabe Y.; Yanagisawa K.; Takahashi T.; miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis 2015,36(12),1464-1473","journal-title":"Carcinogenesis"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","volume":"285","author":"Cui J.G.","year":"2010","unstructured":"Cui J.G.; Li Y.Y.; Zhao Y.; Bhattacharjee S.; Lukiw W.J.; Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 2010,285(50),38951-38960","journal-title":"J Biol Chem"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"e1005073","DOI":"10.1371\/journal.ppat.1005073","volume":"11","author":"Alleaume-Butaux A.","year":"2015","unstructured":"Alleaume-Butaux A.; Nicot S.; Pietri M.; Baudry A.; Dakowski C.; Tixador P.; Ardila-Osorio H.; Haeberl&#xE9; A.M.; Bailly Y.; Peyrin J.M.; Launay J.M.; Kellermann O.; Schneider B.; Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neurito-genesis Defects and Prion Accumulation. PLoS Pathog 2015,11(8),e1005073","journal-title":"PLoS Pathog"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"549875","DOI":"10.5402\/2012\/549875","volume":"2012","author":"Feng B.","year":"2012","unstructured":"Feng B.; Chakrabarti S.; miR-320 Regulates Glucose-Induced Gene Expression in Diabetes. ISRN Endocrinol 2012,2012,549875","journal-title":"ISRN Endocrinol"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2008.02.009","volume":"196","author":"LaCasse R.A.","year":"2008","unstructured":"LaCasse R.A.; Striebel J.F.; Favara C.; Kercher L.; Chesebro B.; Role of Erk1\/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1\/2 activation and accelerated disease progression. J Neuroimmunol 2008,196(1-2),16-26","journal-title":"J Neuroimmunol"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1523\/JNEUROSCI.1701-08.2008","volume":"28","author":"Caetano F.A.","year":"2008","unstructured":"Caetano F.A.; Lopes M.H.; Hajj G.N.; Machado C.F.; Pinto Arantes C.; Magalh&#xE3;es A.C.; Vieira, Mde.P.; Am&#xE9;rico, T.A.; Massensini, A.R.; Priola, S.A.; Vorberg, I.; Gomez, M.V.; Linden, R.; Prado, V.F.; Martins, V.R.; Prado, M.A. Endocytosis of prion protein is required for ERK1\/2 signaling induced by stress-inducible protein 1. J Neurosci 2008,28(26),6691-6702","journal-title":"J Neurosci"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4161\/pri.29021","volume":"8","author":"Rela&#xF1;o-Gin&#xE9;s A.","year":"2014","unstructured":"Rela&#xF1;o-Gin&#xE9;s A.; Lehmann S.; Crozet C.; Prion diseases and adult neurogenesis: how do prions counteract the brain\u2019s endogenous repair machinery? Prion 2014,8(3),240-246","journal-title":"Prion"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1096\/fj.09-134965","volume":"23","author":"Evangelisti C.","year":"2009","unstructured":"Evangelisti C.; Florian M.C.; Massimi I.; Dominici C.; Giannini G.; Galardi S.; Bu&#xE8; M.C.; Massalini S.; McDowell H.P.; Messi E.; Gulino A.; Farace M.G.; Ciafr&#xE8; S.A.; MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J 2009,23(12),4276-4287","journal-title":"FASEB J"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbrc.2016.01.020","volume":"470","author":"Han N.","year":"2016","unstructured":"Han N.; Zhao W.; Zhang Z.; Zheng P.; MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. Biochem Biophys Res Commun 2016,470(1),175-180","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1038\/srep14728","volume":"5","author":"Fan X.Y.","year":"2015","unstructured":"Fan X.Y.; Tian C.; Wang H.; Xu Y.; Ren K.; Zhang B.Y.; Gao C.; Shi Q.; Meng G.; Zhang L.B.; Zhao Y.J.; Shao Q.X.; Dong X.P.; Activation of the AMPK-ULK1 pathway plays an important role in autophagy during prion infection. Sci Rep 2015,5,14728","journal-title":"Sci Rep"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-981-15-4272-5_4","volume":"1207","author":"Hao Z.","year":"2020","unstructured":"Hao Z.; Wang G.; Autophagy and Prion Disease. Adv Exp Med Biol 2020,1207,75-85","journal-title":"Adv Exp Med Biol"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2017.12.011","volume":"112","author":"Burak K.","year":"2018","unstructured":"Burak K.; Lamoureux L.; Boese A.; Majer A.; Saba R.; Niu Y.; Frost K.; Booth S.A.; MicroRNA-16 targets mRNA involved in neurite extension and branching in hippocampal neurons during presymptomatic prion disease. Neurobiol Dis 2018,112,1-13","journal-title":"Neurobiol Dis"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1038\/s41467-020-17655-x","volume":"11","author":"Norsworthy P.J.","year":"2020","unstructured":"Norsworthy P.J.; Thompson A.G.B.; Mok T.H.; Guntoro F.; Dabin L.C.; Nihat A.; Paterson R.W.; Schott J.M.; Collinge J.; Mead S.; Vir&#xE9; E.A.; A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis. Nat Commun 2020,11(1),3960","journal-title":"Nat Commun"},{"key":"ref=338","first-page":"999","volume":"15","author":"Yang Y.T.","year":"2018","unstructured":"Yang Y.T.; Jin S.; Effect of PrP105-132 on the secretion of interleukin-6 and interleukin-8 from microglial cells in vitro. Exp Ther Med 2018,15(1),999-1004","journal-title":"Exp Ther Med"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3892\/or.2016.4676","volume":"35","author":"Fabbri E.","year":"2016","unstructured":"Fabbri E.; Montagner G.; Bianchi N.; Finotti A.; Borgatti M.; Lampronti I.; Cabrini G.; Gambari R.; MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells. Oncol Rep 2016,35(5),2866-2872","journal-title":"Oncol Rep"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1742-4658.2010.07594.x","volume":"277","author":"Xiong J.","year":"2010","unstructured":"Xiong J.; Yu D.; Wei N.; Fu H.; Cai T.; Huang Y.; Wu C.; Zheng X.; Du Q.; Lin D.; Liang Z.; An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 2010,277(7),1684-1694","journal-title":"FEBS J"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"Jovicic A.","year":"2013","unstructured":"Jovicic A.; Zaldivar J.J.F.; Moser R.; Silva S.; Mde.F.; Luthi-Carter, R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PLoS One 2013,8(1),e54222","journal-title":"PLoS One"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1159\/000491543","volume":"47","author":"Chen D.","year":"2018","unstructured":"Chen D.; Hu S.; Wu Z.; Liu J.; Li S.; The Role of MiR-132 in regulating neural stem cell proliferation, differentiation and neuronal matu-ration. Cell Physiol Biochem 2018,47(6),2319-2330","journal-title":"Cell Physiol Biochem"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molcel.2007.07.015","volume":"27","author":"Makeyev E.V.","year":"2007","unstructured":"Makeyev E.V.; Zhang J.; Carrasco M.A.; Maniatis T.; The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007,27(3),435-448","journal-title":"Mol Cell"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4103\/1673-5374.156978","volume":"10","author":"Liu T.","year":"2015","unstructured":"Liu T.; Im, W.; Mook-Jung, I.; Kim, M. MicroRNA-124 slows down the progression of Huntington\u2019s disease by promoting neurogenesis in the striatum. Neural Regen Res 2015,10(5),786-791","journal-title":"Neural Regen Res"},{"key":"ref=345","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fneur.2013.00127","volume":"4","author":"Moumn&#xE9; L.","year":"2013","unstructured":"Moumn&#xE9; L.; Betuing S.; Caboche J.; Multiple Aspects of Gene Dysregulation in Huntington\u2019s Disease. Front Neurol 2013,4,127","journal-title":"Front Neurol"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s12035-014-8803-9","volume":"51","author":"Tan L.","year":"2015","unstructured":"Tan L.; Yu J.T.; Tan L.; Causes and consequences of MicroRNA dysregulation in neurodegenerative diseases. Mol Neurobiol 2015,51(3),1249-1262","journal-title":"Mol Neurobiol"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"e0162788","DOI":"10.1371\/journal.pone.0162788","volume":"11","author":"Kunkanjanawan T.","year":"2016","unstructured":"Kunkanjanawan T.; Carter R.L.; Prucha M.S.; Yang J.; Parnpai R.; Chan A.W.; miR-196a ameliorates cytotoxicity and cellular pheno-type in transgenic Huntington\u2019s disease monkey neural cells. PLoS One 2016,11(9),e0162788","journal-title":"PLoS One"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12920-015-0083-3","volume":"8","author":"Hoss A.G.","year":"2015","unstructured":"Hoss A.G.; Labadorf A.; Latourelle J.C.; Kartha V.K.; Hadzi T.C.; Gusella J.F.; MacDonald M.E.; Chen J.F.; Akbarian S.; Weng Z.; Vonsattel J.P.; Myers R.H.; miR-10b-5p expression in Huntington\u2019s disease brain relates to age of onset and the extent of striatal in-volvement. BMC Med Genomics 2015,8,10","journal-title":"BMC Med Genomics"},{"key":"ref=349","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/mds.26457","volume":"30","author":"Hoss A.G.","year":"2015","unstructured":"Hoss A.G.; Lagomarsino V.N.; Frank S.; Hadzi T.C.; Myers R.H.; Latourelle J.C.; Study of plasma-derived miRNAs mimic differences in Huntington\u2019s disease brain. Mov Disord 2015,30(14),1961-1964","journal-title":"Mov Disord"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2015.10.033","volume":"769","author":"Jamwal S.","year":"2015","unstructured":"Jamwal S.; Kumar P.; Antidepressants for neuroprotection in Huntington\u2019s disease: A review. Eur J Pharmacol 2015,769,33-42","journal-title":"Eur J Pharmacol"},{"key":"ref=351","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"Lewis B.P.","year":"2005","unstructured":"Lewis B.P.; Burge C.B.; Bartel D.P.; Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005,120(1),15-20","journal-title":"Cell"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","volume":"18","author":"Sonkoly E.","year":"2008","unstructured":"Sonkoly E.; St&#xE5;hle M.; Pivarcsi A.; MicroRNAs and immunity: novel players in the regulation of normal immune function and inflamma-tion. Semin Cancer Biol 2008,18(2),131-140","journal-title":"Semin Cancer Biol"},{"key":"ref=353","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","volume":"396","author":"Sinha M.","year":"2010","unstructured":"Sinha M.; Ghose J.; Das E.; Bhattarcharyya N.P.; Altered microRNAs in STHdh(Q111)\/Hdh(Q111) cells: miR-146a targets TBP. Biochem Biophys Res Commun 2010,396(3),742-747","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuint.2018.04.015","volume":"123","author":"Laprairie R.B.","year":"2019","unstructured":"Laprairie R.B.; Petr G.T.; Sun Y.; Fischer K.D.; Denovan-Wright E.M.; Rosenberg P.A.; Huntington\u2019s disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1. Neurochem Int 2019,123,85-94","journal-title":"Neurochem Int"},{"key":"ref=355","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.4161\/rna.8.6.16035","volume":"8","author":"Sinha M.","year":"2011","unstructured":"Sinha M.; Ghose J.; Bhattarcharyya N.P.; Micro RNA -214,-150,-146a and-125b target Huntingtin gene. RNA Biol 2011,8(6),1005-1021","journal-title":"RNA Biol"},{"key":"ref=356","doi-asserted-by":"publisher","first-page":"16999","DOI":"10.3390\/ijms140816999","volume":"14","author":"Kozlowska E.","year":"2013","unstructured":"Kozlowska E.; Krzyzosiak W.J.; Koscianska E.; Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respec-tive isomiRs. Int J Mol Sci 2013,14(8),16999-17016","journal-title":"Int J Mol Sci"},{"key":"ref=357","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-017-0742-x","volume":"12","author":"Chang K.H.","year":"2017","unstructured":"Chang K.H.; Wu Y.R.; Chen C.M.; Down-regulation of miR-9* in the peripheral leukocytes of Huntington\u2019s disease patients. Orphanet J Rare Dis 2017,12(1),185","journal-title":"Orphanet J Rare Dis"},{"key":"ref=358","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2051-5960-1-42","volume":"1","author":"Freischmidt A.","year":"2013","unstructured":"Freischmidt A.; M&#xFC;ller K.; Ludolph A.C.; Weishaupt J.H.; Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun 2013,1,42","journal-title":"Acta Neuropathol Commun"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19051318","volume":"19","author":"Taguchi Y.H.","year":"2018","unstructured":"Taguchi Y.H.; Wang H.; Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis. Int J Mol Sci 2018,19(5),19","journal-title":"Int J Mol Sci"},{"key":"ref=360","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1038\/s41598-018-23139-2","volume":"8","author":"Kovanda A.","year":"2018","unstructured":"Kovanda A.; Leonardis L.; Zidar J.; Koritnik B.; Dolenc-Groselj L.; Ristic Kovacic S.; Curk T.; Rogelj B.; Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep 2018,8(1),5609","journal-title":"Sci Rep"},{"key":"ref=361","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1352458516651141","volume":"23","author":"Vistbakka J.","year":"2017","unstructured":"Vistbakka J.; Elovaara I.; Lehtim&#xE4;ki T.; Hagman S.; Circulating microRNAs as biomarkers in progressive multiple sclerosis. Mult Scler 2017,23(3),403-412","journal-title":"Mult Scler"},{"key":"ref=362","doi-asserted-by":"publisher","first-page":"10046","DOI":"10.1038\/s41598-017-10488-7","volume":"7","author":"D\u2019Erchia A.M.","year":"2017","unstructured":"D\u2019Erchia A.M.; Gallo A.; Manzari C.; Raho S.; Horner D.S.; Chiara M.; Valletti A.; Aiello I.; Mastropasqua F.; Ciaccia L.; Locatelli F.; Pisani F.; Nicchia G.P.; Svelto M.; Pesole G.; Picardi E.; Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci Rep 2017,7(1),10046","journal-title":"Sci Rep"},{"key":"ref=363","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lfs.2017.12.016","volume":"193","author":"Recabarren-Leiva D.","year":"2018","unstructured":"Recabarren-Leiva D.; Alarc&#xF3;n M.; New insights into the gene expression associated to amyotrophic lateral sclerosis. Life Sci 2018,193,110-123","journal-title":"Life Sci"},{"key":"ref=364","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","volume":"11","author":"Liguori M.","year":"2018","unstructured":"Liguori M.; Nuzziello N.; Introna A.; Consiglio A.; Licciulli F.; D\u2019Errico E.; Scarafino A.; Distaso E.; Simone I.L.; Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front Mol Neurosci 2018,11,288","journal-title":"Front Mol Neurosci"},{"key":"ref=365","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/hmg\/ddx385","volume":"27","author":"Liguori M.","year":"2018","unstructured":"Liguori M.; Nuzziello N.; Licciulli F.; Consiglio A.; Simone M.; Viterbo R.G.; Creanza T.M.; Ancona N.; Tortorella C.; Margari L.; Grillo G.; Giordano P.; Liuni S.; Trojano M.; Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an in-tegrated approach to uncover novel pathogenic mechanisms of the disease. Hum Mol Genet 2018,27(1),66-79","journal-title":"Hum Mol Genet"},{"key":"ref=366","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/BMI.S25132","volume":"10","author":"Satoh J.","year":"2015","unstructured":"Satoh J.; Kino Y.; Niida S.; MicroRNA-seq data analysis pipeline to identify blood biomarkers for Alzheimer\u2019s disease from public data. Biomark Insights 2015,10,21-31","journal-title":"Biomark Insights"},{"key":"ref=367","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19051534","volume":"19","author":"Di Pietro L.","year":"2018","unstructured":"Di Pietro L.; Lattanzi W.; Bernardini C.; Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclero-sis. Int J Mol Sci 2018,19(5),19","journal-title":"Int J Mol Sci"},{"key":"ref=368","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.1038\/s41598-017-14301-3","volume":"7","author":"Ebrahimkhani S.","year":"2017","unstructured":"Ebrahimkhani S.; Vafaee F.; Young P.E.; Hur S.S.J.; Hawke S.; Devenney E.; Beadnall H.; Barnett M.H.; Suter C.M.; Buckland M.E.; Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep 2017,7(1),14293","journal-title":"Sci Rep"},{"key":"ref=369","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.12659\/MSM.905064","volume":"23","author":"Chang W.S.","year":"2017","unstructured":"Chang W.S.; Wang Y.H.; Zhu X.T.; Wu C.J.; Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer\u2019s Disease. Med Sci Monit 2017,23,2721-2731","journal-title":"Med Sci Monit"},{"key":"ref=370","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2018.02.009","volume":"114","author":"Si Y.","year":"2018","unstructured":"Si Y.; Cui X.; Crossman D.K.; Hao J.; Kazamel M.; Kwon Y.; King P.H.; Muscle microRNA signatures as biomarkers of disease pro-gression in amyotrophic lateral sclerosis. Neurobiol Dis 2018,114,85-94","journal-title":"Neurobiol Dis"},{"key":"ref=371","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mus.26106","volume":"58","author":"Raheja R.","year":"2018","unstructured":"Raheja R.; Regev K.; Healy B.C.; Mazzola M.A.; Beynon V.; Von Glehn F.; Paul A.; Diaz-Cruz C.; Gholipour T.; Glanz B.I.; Kivi-sakk P.; Chitnis T.; Weiner H.L.; Berry J.D.; Gandhi R.; Correlating serum micrornas and clinical parameters in amyotrophic lateral scle-rosis. Muscle Nerve 2018,58(2),261-269","journal-title":"Muscle Nerve"},{"key":"ref=372","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnmol.2015.00005","volume":"8","author":"Devier D.J.","year":"2015","unstructured":"Devier D.J.; Lovera J.F.; Lukiw W.J.; Increase in NF-&#x3BA;B-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration. Front Mol Neurosci 2015,8,5","journal-title":"Front Mol Neurosci"},{"key":"ref=373","doi-asserted-by":"publisher","first-page":"4578230","DOI":"10.1155\/2016\/4578230","volume":"2016","author":"Wu T.","year":"2016","unstructured":"Wu T.; Chen G.; miRNAs Participate in MS Pathological Processes and Its Therapeutic Response. Mediators Inflamm 2016,2016,4578230","journal-title":"Mediators Inflamm"},{"key":"ref=374","first-page":"807426","volume":"2011","author":"Tufekci K.U.","year":"2010","unstructured":"Tufekci K.U.; Oner M.G.; Genc S.; Genc K.; MicroRNAs and multiple sclerosis. Autoimmune Dis 2010,2011,807426","journal-title":"Autoimmune Dis"},{"key":"ref=375","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fnins.2018.00465","volume":"12","author":"Hu Z.","year":"2018","unstructured":"Hu Z.; Cui Y.; Qiao X.; He X.; Li F.; Luo C.; Wang S.; Li C.; Dai R.; Silencing miR-150 ameliorates experimental autoimmune en-cephalomyelitis. Front Neurosci 2018,12,465","journal-title":"Front Neurosci"},{"key":"ref=376","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/brain\/awr200","volume":"134","author":"Noorbakhsh F.","year":"2011","unstructured":"Noorbakhsh F.; Ellestad K.K.; Maingat F.; Warren K.G.; Han M.H.; Steinman L.; Baker G.B.; Power C.; Impaired neurosteroid syn-thesis in multiple sclerosis. Brain 2011,134(Pt 9),2703-2721","journal-title":"Brain"},{"key":"ref=377","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.biopha.2018.05.050","volume":"104","author":"Dolati S.","year":"2018","unstructured":"Dolati S.; Marofi F.; Babaloo Z.; Aghebati-Maleki L.; Roshangar L.; Ahmadi M.; Rikhtegar R.; Yousefi M.; Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis. Biomed Pharmacother 2018,104,280-290","journal-title":"Biomed Pharmacother"},{"key":"ref=378","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12920-018-0365-7","volume":"11","author":"Groen K.","year":"2018","unstructured":"Groen K.; Maltby V.E.; Lea R.A.; Sanders K.A.; Fink J.L.; Scott R.J.; Tajouri L.; Lechner-Scott J.; Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis. BMC Med Genomics 2018,11(1),48","journal-title":"BMC Med Genomics"},{"key":"ref=379","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-012-1052-y","volume":"125","author":"Witte M.E.","year":"2013","unstructured":"Witte M.E.; Nijland P.G.; Drexhage J.A.; Gerritsen W.; Geerts D.; van Het Hof B.; Reijerkerk A.; de Vries H.E.; van der Valk P.; van Horssen J.; Reduced expression of PGC-1&#x3B1; partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol 2013,125(2),231-243","journal-title":"Acta Neuropathol"},{"key":"ref=380","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12944-020-01261-3","volume":"19","author":"Zhang Q.","year":"2020","unstructured":"Zhang Q.; Ma X.F.; Dong M.Z.; Tan J.; Zhang J.; Zhuang L.K.; Liu S.S.; Xin Y.N.; MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line. Lipids Health Dis 2020,19(1),76","journal-title":"Lipids Health Dis"},{"key":"ref=381","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jneuroim.2018.10.002","volume":"325","author":"Tavakolpour V.","year":"2018","unstructured":"Tavakolpour V.; Shokri G.; Naser Moghadasi A.; Mozafari Nahavandi P.; Hashemi M.; Kouhkan F.; Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and dis-ease activity. J Neuroimmunol 2018,325,79-86","journal-title":"J Neuroimmunol"},{"key":"ref=382","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7150\/ijms.8647","volume":"11","author":"Ma X.","year":"2014","unstructured":"Ma X.; Zhou J.; Zhong Y.; Jiang L.; Mu P.; Li Y.; Singh N.; Nagarkatti M.; Nagarkatti P.; Expression, regulation and function of mi-croRNAs in multiple sclerosis. Int J Med Sci 2014,11(8),810-818","journal-title":"Int J Med Sci"},{"key":"ref=383","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1177\/1352458513485654","volume":"19","author":"Fenoglio C.","year":"2013","unstructured":"Fenoglio C.; Ridolfi E.; Cantoni C.; De Riz M.; Bonsi R.; Serpente M.; Villa C.; Pietroboni A.M.; Naismith R.T.; Alvarez E.; Parks B.J.; Bresolin N.; Cross A.H.; Piccio L.M.; Galimberti D.; Scarpini E.; Decreased circulating miRNA levels in patients with primary pro-gressive multiple sclerosis. Mult Scler 2013,19(14),1938-1942","journal-title":"Mult Scler"},{"key":"ref=384","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/brain\/awp300","volume":"132","author":"Junker A.","year":"2009","unstructured":"Junker A.; Krumbholz M.; Eisele S.; Mohan H.; Augstein F.; Bittner R.; Lassmann H.; Wekerle H.; Hohlfeld R.; Meinl E.; MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009,132(Pt 12),3342-3352","journal-title":"Brain"},{"key":"ref=385","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1523\/JNEUROSCI.2830-15.2015","volume":"35","author":"Mycko M.P.","year":"2015","unstructured":"Mycko M.P.; Cichalewska M.; Cwiklinska H.; Selmaj K.W.; miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40. J Neurosci 2015,35(50),16504-16515","journal-title":"J Neurosci"},{"key":"ref=386","doi-asserted-by":"publisher","first-page":"12446","DOI":"10.1074\/jbc.M114.550723","volume":"289","author":"Liu S.Q.","year":"2014","unstructured":"Liu S.Q.; Jiang S.; Li C.; Zhang B.; Li Q.J.; miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. J Biol Chem 2014,289(18),12446-12456","journal-title":"J Biol Chem"},{"key":"ref=387","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.immuni.2016.05.015","volume":"44","author":"Ichiyama K.","year":"2016","unstructured":"Ichiyama K.; Gonzalez-Martin A.; Kim B.S.; Jin H.Y.; Jin W.; Xu W.; Sabouri-Ghomi M.; Xu S.; Zheng P.; Xiao C.; Dong C.; The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expres-sion. Immunity 2016,44(6),1284-1298","journal-title":"Immunity"},{"key":"ref=388","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19113652","volume":"19","author":"Nuzziello N.","year":"2018","unstructured":"Nuzziello N.; Vilardo L.; Pelucchi P.; Consiglio A.; Liuni S.; Trojano M.; Liguori M.; Investigating the Role of MicroRNA and Tran-scription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis. Int J Mol Sci 2018,19(11),19","journal-title":"Int J Mol Sci"},{"key":"ref=389","year":"2020","unstructured":"Cardiac Changes in Early Parkinson's Disease: A Follow up Study.\nIn: ClinicalTrialsgov 2020","journal-title":"ClinicalTrialsgov"},{"key":"ref=390","year":"2020","unstructured":"Safety Evaluation of Cellavita HD Administered Intravenously in\nParticipants With Huntington's Disease (SAVE-DH). In: Clinical-\nTrialsgov 2020","journal-title":"Clinical-\nTrialsgov"},{"key":"ref=391","year":"2020","unstructured":"CJD (Creutzfeldt-Jakob Disease) Quinacrine Study. In: Clinical-\nTrialsgov 2020","journal-title":"Clinical-\nTrialsgov"},{"key":"ref=392","year":"2020","unstructured":"Human Neural Stem Cell Transplantation in Amyotrophic Lateral\nSclerosis (ALS) (hNSCALS). In: ClinicalTrialsgov 2020","journal-title":"ClinicalTrialsgov"},{"key":"ref=393","year":"2020","unstructured":"Neural Stem Cell Transplantation in Multiple Sclerosis Patients\n(STEMS). In: ClinicalTrialsgov 2020","journal-title":"ClinicalTrialsgov"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X19666210817150141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195709\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X19666210817150141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:23:47Z","timestamp":1747308227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195709\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":393,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x19666210817150141","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}